Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 94
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Multilocus genetic risk scores for venous thromboembolism risk assessment

  • Soria Fernández, José Manuel|||0000-0002-6226-4293
  • Morange, Pierre-Emmanuel|||0000-0002-9065-722X
  • Vila, Joan
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Moyano, Manel
  • Trégouët, David-Alexandre|||0000-0001-9084-7800
  • Mateo, Jose|||0000-0002-4227-3256
  • Saut, Noémi
  • Salas, Eduardo|||0000-0002-6837-2471
  • Elosua, Roberto|||0000-0001-8235-0095
Background-Genetics plays an important role in venous thromboembolism (VTE). Factor V Leiden (FVL or rs6025) and prothrombin gene G20210A (PT or rs1799963) are the genetic variants currently tested for VTE risk assessment. We hypothesized that primary VTE risk assessment can be improved by using genetic risk scores with more genetic markers than just FVL-rs6025 and prothrombin gene PT-rs1799963. To this end, we have designed a new genetic risk score called Thrombo inCode (TiC). Methods and Results-TiC was evaluated in terms of discrimination (Δ of the area under the receiver operating characteristic curve) and reclassification (integrated discrimination improvement and net reclassification improvement). This evaluation was performed using 2 age- and sex-matched case-control populations: SANTPAU (248 cases, 249 controls) and the Marseille Thrombosis Association study (MARTHA; 477 cases, 477 controls). TiC was compared with other literature-based genetic risk scores. TiC including F5 rs6025/rs118203906/rs118203905, F2 rs1799963, F12 rs1801020, F13 rs5985, SERPINC1 rs121909548, and SERPINA10 rs2232698 plus the A1 blood group (rs8176719, rs7853989, rs8176743, rs8176750) improved the area under the curve compared with a model based only on F5-rs6025 and F2-rs1799963 in SANTPAU (0.677 versus 0.575, P<0.001) and MARTHA (0.605 versus 0.576, P=0.008). TiC showed good integrated discrimination improvement of 5.49 (P<0.001) for SANTPAU and 0.96 (P=0.045) for MARTHA. Among the genetic risk scores evaluated, the proportion of VTE risk variance explained by TiC was the highest. Conclusions-We conclude that TiC greatly improves prediction of VTE risk compared with other genetic risk scores. TiC should improve prevention, diagnosis, and treatment of VTE.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inflammatory biomarkers in type 2 diabetic patients, Effect of glycemic control and impact of ldl subfraction phenotype

  • Vinagre, Irene|||0000-0001-8760-3370
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
  • Sánchez-Hernández, Juan
  • Santos, David|||0000-0003-1157-4969
  • Ordóñez, J. (Jordi)|||0000-0003-4896-5832
  • De Leiva Hidalgo, Alberto|||0000-0002-0419-6771
  • Pérez, Antonio|||0000-0001-5528-1143
Background: Type 2 diabetes mellitus (T2D) is associated with higher cardiovascular risk partly related to an increase in inflammatory parameters. The aim of this study was to determine the association of inflammatory biomarkers with low-density lipoprotein (LDL) subfraction phenotype and glycemic control in subjects with T2D and poor glycemic control.Methods: A cross-sectional study was performed comparing 122 subjects with T2D (59 ± 11 years old, body mass index 30.2 ± 5.6 kg/m2) with 54 control subjects. Patients with T2D were classified according to their LDL subfraction phenotype and inflammatory biomarkers (C-reactive protein, Interleukin-6, Interleukin-8, Transforming growth factor β, Monocyte chemotactic protein 1, Leptin, Adiponectin) were evaluated according to the degree of glycemic control, LDL phenotype and other clinical characteristics. Forty-two subjects with T2D were studied before and after 3 months of improving glycemic control by different strategies.Results: Patients with T2D had higher C-reactive protein (CRP) and monocyte chemotactic protein-1 (MCP1) levels and lower adiponectin concentration, compared to controls. T2D subjects with body mass index ≥ 30 kg/m2 had higher CRP levels (5.2 ± 4.8 mg/l vs 3.7 ± 4.3 mg/l; p < 0.05). The presence of LDL phenotype B was related to higher levels of transforming growth factor-β (TGF-β) (53.92 ± 52.82 ng/l vs 31.35 ± 33.74 ng/l; p < 0.05) and lower levels of adiponectin (3663 ± 3044 ng/l vs 2723 ± 1776 ng/l; p < 0.05). The reduction of HbA1c from 9.5 ± 1.8% at baseline to 7.4 ± 0.8% was associated with a significant reduction of TGF-β (41.86 ± 32.84 ng/l vs 26.64 ± 26.91 ng/l; p = 0.02).Conclusions: Subjects with T2D, especially those with LDL phenotype B and obesity, have higher levels of inflammatory biomarkers. Improvement of glycemic control reduces TGF-β levels, which may contribute partly to its renoprotective role. © 2014 Vinagre et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Electronegative LDL, A circulating modified LDL with a role in inflammation

  • Estruch, Montserrat|||0000-0002-7162-4158
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
  • Ordóñez, J. (Jordi)|||0000-0003-4896-5832
  • Benitez, Sonia|||0000-0003-3565-0743
Electronegative low density lipoprotein (LDL(-)) is a minor modified fraction of LDL found in blood. It comprises a heterogeneous population of LDL particles modified by various mechanisms sharing as a common feature increased electronegativity. Modification by oxidation is one of these mechanisms. LDL(-) has inflammatory properties similar to those of oxidized LDL (oxLDL), such as inflammatory cytokine release in leukocytes and endothelial cells. However, in contrast with oxLDL, LDL(-) also has some anti-inflammatory effects on cultured cells. The inflammatory and anti-inflammatory properties ascribed to LDL(-) suggest that it could have a dual biological effect. © 2013 Montserrat Estruch et al.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Left and Right Ventricle Late Remodeling Following Myocardial Infarction in Rats

  • Stefanon, Ivanita
  • Valero-Muñoz, María
  • Fernandes, Aurélia Araújo
  • Ribeiro, Rogério Faustino
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Miana, Maria
  • Martínez-González, José|||0000-0002-3894-7166
  • Spalenza, Jessica S.
  • Lahera, Vicente
  • Vassallo, Paula F.
  • Cachofeiro, Victoria
Background:The mechanisms involved in cardiac remodeling in left (LV) and right ventricles (RV) after myocardial infarction (MI) are still unclear. We assayed factors involved in collagen turnover in both ventricles following MI in rats either presenting signs of heart failure (pulmonary congestion and increased LVEDP) or not (INF-HF or INF, respectively).Methods:MI was induced in male rats by ligation of the left coronary artery. Four weeks after MI gene expression of collagen I, connective tissue growth factor (CTGF), transforming growth factor β (TGF-β) and lysyl oxidase (LOX), metalloproteinase-2 (MMP2) and tissue inhibitor metalloproteinase-2 (TIMP2) as well as cardiac hemodynamic in both ventricles were evaluated.Results:Ventricular dilatation, hypertrophy and an increase in interstitial fibrosis and myocyte size were observed in the RV and LV from INF-HF animals, whereas only LV dilatation and fibrosis in RV was present in INF. The LV fibrosis in INF-HF was associated with higher mRNA of collagen I, CTGF, TGF-β and LOX expressions than in INF and SHAM animals, while MMP2/TIMP2 mRNA ratio did not change. RV fibrosis in INF and INF-HF groups was associated with an increase in LOX mRNA and a reduction in MMP2/TIMP2 ratio. CTGF mRNA was increased only in the INF-HF group.Conclusions:INF and INF-HF animals presented different patterns of remodeling in both ventricles. In the INF-HF group, fibrosis seems to be consequence of collagen production in LV, and by reductions in collagen degradation in RV of both INF and INF-HF animals. © 2013 Stefanon et al.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Stem cells isolated from adipose tissue of obese patients show changes in their transcriptomic profile that indicate loss in stemcellness and increased commitment to an adipocyte-like phenotype

  • Oñate, Blanca
  • Vilahur, Gemma|||0000-0002-2828-8873
  • Camino-López, Sandra|||0000-0002-2737-4892
  • Díez-Caballero, Alberto
  • Ballesta-López, Carlos
  • Ybarra, Juan
  • Moscatiello, Fabrizio
  • Herrero, Javier
  • Badimon, Lina|||0000-0002-9162-2459
Background: The adipose tissue is an endocrine regulator and a risk factor for atherosclerosis and cardiovascular disease when by excessive accumulation induces obesity. Although the adipose tissue is also a reservoir for stem cells (ASC) their function and " stemcellness" has been questioned. Our aim was to investigate the mechanisms by which obesity affects subcutaneous white adipose tissue (WAT) stem cells.Results: Transcriptomics, in silico analysis, real-time polymerase chain reaction (PCR) and western blots were performed on isolated stem cells from subcutaneous abdominal WAT of morbidly obese patients (ASCmo) and of non-obese individuals (ASCn). ASCmo and ASCn gene expression clustered separately from each other. ASCmo showed downregulation of " stemness" genes and upregulation of adipogenic and inflammatory genes with respect to ASCn. Moreover, the application of bioinformatics and Ingenuity Pathway Analysis (IPA) showed that the transcription factor Smad3 was tentatively affected in obese ASCmo. Validation of this target confirmed a significantly reduced Smad3 nuclear translocation in the isolated ASCmo.Conclusions: The transcriptomic profile of the stem cells reservoir in obese subcutaneous WAT is highly modified with significant changes in genes regulating stemcellness, lineage commitment and inflammation. In addition to body mass index, cardiovascular risk factor clustering further affect the ASC transcriptomic profile inducing loss of multipotency and, hence, capacity for tissue repair. In summary, the stem cells in the subcutaneous WAT niche of obese patients are already committed to adipocyte differentiation and show an upregulated inflammatory gene expression associated to their loss of stemcellness. © 2013 Oñate et al.; licensee BioMed Central Ltd.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Is the ORBIT bleeding risk score superior to the HAS-BLED score in anticoagulated atrial fibrillation patients?

  • Esteve-Pastor, María Asunción
  • García-Fernández, Amaya
  • Macías, Manuel
  • Segorb, Francisco
  • Valdés, Mariano
  • Roldán, Vanessa
  • Muñiz, Javier
  • Badimón, Lina
  • Roldán Rabadán, Inmaculada
  • Bertomeu-Martínez, Vicente
  • Cequier, Ángel
  • Lip, Gregory Y.H.
  • Anguita, Manuel
  • Marín, Francisco
Multicenter study, [Abstract] Background: Several bleeding risk scores have been validated in patients with atrial fibrillation (AF). The ORBIT score has been recently proposed as a simple score with the best ability to predict major bleeding. The present study aimed to test the hypothesis that the ORBIT score was superior to the HAS-BLED score for predicting major bleeding and death in "real world" anticoagulated AF patients. Methods and results: We analyzed the predictive performance for bleeding and death of 406 AF patients who underwent 571 electrical cardioversion procedures and 1,276 patients with permanent/persistent AF from the FANTASIIA registry. In the cardioversion population, 21 patients had major bleeding events and 26 patients died. The predictive performance for major bleeding of HAS-BLED and ORBIT were not significantly different (c-statistics 0.77 (95% CI 0.66-0.88) and 0.82 (95% CI 0.77-0.93), respectively; P=0.080). For the FANTASIIA population, 46 patients had major bleeding events and 50 patients died. The predictive performances for major bleeding of HAS-BLED and ORBIT were not significantly different (c-statistics 0.63 (95% CI 0.56-0.71) and 0.70 (95% CI 0.62-0.77), respectively; P=0.116). For death, the predictive performances of HAS-BLED and ORBIT were not significantly different in both populations. The ORBIT score categorized most patients as "low risk". Conclusions: Despite the original claims in its derivation paper, the ORBIT score was not superior to HAS-BLED for predicting major bleeding and death in a "real world" oral anticoagulated AF population. (Circ J 2016; 80: 2102-2108)., The FANTASIIA registry was funded by an unconditional grant from Pfizer/Bristol-Myers-Squibb and by grants from the Instituto de Salud Carlos III (Madrid)-FEDER (RD12/0042/0068, RD12/0042/0010, RD12/0042/0069 and RD12/0042/0063). The authors are supported by RD12/0042/0049 (RETICS) from ISCIII and PI13/00513/FEDER from ISCIII.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lysyl oxidase (LOX) in vascular remodelling. Insight from a new animal model

  • Orriols, Mar
  • Guadall, Anna
  • Galán, María
  • Martí-Pàmies, Ingrid
  • Varona, Saray
  • Rodríguez-Calvo, Ricardo
  • Briones, Ana María
  • Navarro, María A.
  • Diego, Alicia de
  • Osada, Jesús
  • Martínez-González, José
  • Rodríguez-Sinovas, Cristina
Lysyl oxidase (LOX) is an extracellular matrix-modifying enzyme that seems to play a critical role in vascular remodelling. However, the lack of viable LOX-deficient animal models has been an obstacle to deep in LOX biology. In this study we have developed a transgenic mouse model that over-expresses LOX in vascular smooth muscle cells (VSMC) to clarify whether LOX could regulate VSMC phenotype and vascular remodelling. The SM22α proximal promoter drove the expression of a transgene containing the human LOX cDNA. Two stable transgenic lines, phenotypically indistinguishable, were generated by conventional methods (TgLOX). Transgene expression followed the expected SMC-specific pattern. In TgLOX mice, real-time PCR and immunohistochemistry evidenced a strong expression of LOX in the media from aorta and carotid arteries, coincident with a higher proportion of mature collagen. VSMC isolated from TgLOX mice expressed high levels of LOX pro-enzyme, which was properly secreted and processed into mature and bioactive LOX. Interestingly, cell proliferation was significantly reduced in cells from TgLOX mice. Transgenic VSMC also exhibited low levels of Myh10 (marker of SMC phenotypic switching), PCNA (marker of cell proliferation) and MCP-1, and a weak activation of Akt and ERK1/2 in response to mitogenic stimuli. Accordingly, neointimal thickening induced by carotid artery ligation was attenuated in TgLOX mice that also displayed a reduction in PCNA and MCP-1 immunostaining. Our results give evidence that LOX plays a critical role in vascular remodelling. We have developed a new animal model to study the role of LOX in vascular biology., This work was supported by Sociedad Española de Cardiología (Proyecto SEC para Investigación Básica 2012) and the Spanish Ministerio de Economía y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) [grants PI12/01952, SAF2012–40127, RD12/0042/0053 and RD12/0042/0024]. AG and MG were supported by funds provided by Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (PFIS and Sara Borrell programs respectively) and AMB is supported through the Ramón y Cajal program (RYC-2010–06473)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats

  • Miana, María
  • Galán, María
  • Martínez-Martínez, Ernesto
  • Varona, Saray
  • Jurado-López, Raquel
  • Bausa-Miranda, Belén
  • Antequera, Alfonso
  • Luaces, María
  • Martínez-González, José
  • Tejedor-Rodríguez, Cristina
  • Cachofeiro, Victoria
Extracellular matrix (ECM) remodelling of the adipose tissue plays a pivotal role in the pathophysiology of obesity. The lysyl oxidase (LOX) family of amine oxidases, including LOX and LOX-like (LOXL) isoenzymes, controls ECM maturation, and upregulation of LOX activity is essential in fibrosis; however, its involvement in adipose tissue dysfunction in obesity is unclear. In this study, we observed that LOX is the main isoenzyme expressed in human adipose tissue and that its expression is strongly upregulated in samples from obese individuals that had been referred to bariatric surgery. LOX expression was also induced in the adipose tissue from male Wistar rats fed a high-fat diet (HFD). Interestingly, treatment with β-aminopropionitrile (BAPN), a specific and irreversible inhibitor of LOX activity, attenuated the increase in body weight and fat mass that was observed in obese animals and shifted adipocyte size toward smaller adipocytes. BAPN also ameliorated the increase in collagen content that was observed in adipose tissue from obese animals and improved several metabolic parameters - it ameliorated glucose and insulin levels, decreased homeostasis model assessment (HOMA) index and reduced plasma triglyceride levels. Furthermore, in white adipose tissue from obese animals, BAPN prevented the downregulation of adiponectin and glucose transporter 4 (GLUT4), as well as the increase in suppressor of cytokine signaling 3 (SOCS3) and dipeptidyl peptidase 4 (DPP4) levels, triggered by the HFD. Likewise, in the TNFα-induced insulin-resistant 3T3-L1 adipocyte model, BAPN prevented the downregulation of adiponectin and GLUT4 and the increase in SOCS3 levels, and consequently normalised insulin-stimulated glucose uptake. Therefore, our data provide evidence that LOX plays a pathologically relevant role in the metabolic dysfunction induced by obesity and emphasise the interest of novel pharmacological interventions that target adipose tissue fibrosis and LOX activity for the clinical management of this disease., This work was supported by Plan Estatal I+D+I 2013-2016 [PI12/01729, PI12/01952] and Red de Investigación Cardiovascular [RD12/0042/0033 and RD12/0042/0053] of the Instituto de Salud Carlos III (ISCIII), as well as the Ministerio de Economía y Competitividad (MINECO) [SAF2012-40127]. The study was cofunded by Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe. M.G. was supported by the Sara Borrell Program from ISCIII (CD12/00589)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NOR-1 modulates the inflammatory response of vascular smooth muscle cells by preventing NFκB activation

  • Calvayrac, Olivier
  • Rodríguez-Calvo, Ricardo
  • Martí-Pamies, Ingrid
  • Alonso, Judith
  • Ferrán, Beatriz
  • Aguiló, Silvia
  • Crespo, Javier
  • Rodríguez-Sinovas, Antonio
  • Tejedor-Rodríguez, Cristina
  • Martínez-González, José
Recent work has highlighted the role of NR4A receptors in atherosclerosis and inflammation. In vascular smooth muscle cell (VSMC) proliferation, however, NOR-1 (neuron-derived orphan receptor-1) exerts antagonistic effects to Nur77 and Nurr1. The aim of this study was to analyse the effect of NOR-1 in VSMC inflammatory response. We assessed the consequence of a gain-of-function of this receptor on the response of VSMC to inflammatory stimuli. In human VSMC, lentiviral over-expression of NOR-1 reduced lipopolysaccharide (LPS)-induced up-regulation of cytokines (IL-1β, IL-6 and IL-8) and chemokines (MCP-1 and CCL20). Similar effects were obtained in cells stimulated with TNFα or oxLDL. Conversely, siRNA-mediated NOR-1 inhibition significantly increased the expression of pro-inflammatory mediators. Interestingly, in the aortas from transgenic mice that over-express human NOR-1 in VSMC (TgNOR-1), the up-regulation of cytokine/chemokine by LPS was lower compared to wild-type littermates. Similar results were obtained in VSMC from transgenic animals. NOR-1 reduced the transcriptional activity of NFκB sensitive promoters (in transient transfections), and the binding of NFκB to its responsive element (in electrophoretic mobility shift assays). Furthermore, NOR-1 prevented the activation of NFκB pathway by decreasing IκBα phosphorylation/degradation and inhibiting the phosphorylation and subsequent translocation of p65 to the nucleus (assessed by Western blot and immunocytochemistry). These effects were associated with an attenuated phosphorylation of ERK1/2, p38 MAPK and Jun N-terminal kinase, pathways involved in the activation of NFκB. In mouse challenged with LPS, the activation of the NFκB signalling was also attenuated in the aorta from TgNOR-1. Our data support a role for NOR-1 as a negative modulator of the acute response elicited by pro-inflammatory stimuli in the vasculature., This work was supported by the Sociedad Española de Cardiología (Proyecto Fundación Española del Corazón para Investigación Básica en Cardiología 2011) and Spanish Ministerio de Economía y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) [SAF2009-11949, SAF2012-40127, PI12/01952, RD12/0042/0053 and RD12/0042/0021]. Judith Alonso is supported by a Ph.D. fellowship (FPU) from the Spanish Ministerio de Educación, and Beatriz Ferrán by a JAE-Pre from the Consejo Superior de Investigaciones Científicas (CSIC)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Down-regulation of Fibulin-5 is associated with aortic dilation: role of inflammation and epigenetics

  • Orriols, Mar
  • Varona, Saray
  • Martí-Pàmies, Ingrid
  • Galán, María
  • Guadall, Anna
  • Escudero, José Román
  • Martín-Ventura, José Luis
  • Camacho, Mercedes
  • Vila, Luis
  • Martínez-González, José
  • Rodríguez-Sinovas, Cristina
Aims Destructive remodelling of extracellular matrix (ECM) and inflammation lead to dilation and ultimately abdominal aortic aneurysm (AAA). Fibulin-5 (FBLN5) mediates cell–ECM interactions and elastic fibre assembly and is critical for ECM remodelling. We aimed to characterize FBLN5 regulation in human AAA and analyse the underlying mechanisms. Methods and results FBLN5 expression was significantly decreased in human aneurysmatic aortas compared with healthy vessels. Local FBLN5 knockdown promoted aortic dilation and enhanced vascular expression of inflammatory markers in Ang II-infused C57BL/6J mice. Inflammatory stimuli down-regulated FBLN5 expression and transcriptional activity in human aortic vascular smooth muscle cells (VSMC). Further, aortic FBLN5 expression was reduced in LPS-challenged mice. A SOX response element was critical for FBLN5 promoter activity. The SOX9 expression pattern in human AAA parallels that of FBLN5, and like FBLN5, it was reduced in TNFα-stimulated VSMC. Interestingly, SOX9 over-expression prevented the cytokine-mediated reduction of FBLN5 expression and transcription. The inhibition of Class I histone deacetylases (HDACs) by MS-275 or gene silencing attenuated the inflammation-mediated decrease of FBLN5 expression in VSMC and in the vascular wall. Consistently, HDAC inhibition counteracted the reduction of SOX9 expression induced by inflammatory stimuli and prevented the TNFα-mediated decrease in the binding of SOX9 to FBLN5 promoter normalizing FBLN5 expression. Conclusion We evidence the deregulation of FBLN5 in human AAA and identify a SOX9/HDAC-dependent mechanism involved in the down-regulation of FBLN5 by inflammation. HDAC inhibitors or pharmacological approaches that aimed to preserve FBLN5 could be useful to prevent the disorganization of ECM induced by inflammation in AAA., This work was supported by the Spanish Ministerio de Economía y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) (grants PI15/01016, PI12/01952, SAF2012-40127, SAF2013-46707-R, SAF2015-64767-R, RD12/0042/0053, RD12/0042/0051 and RD12/0042/0038). A.G. and M.G. were supported by funds provided by ISCIII (PFIS and Sara Borrell programs, respectively). The study was co-founded by Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Glycated hemoglobin, fasting insulin and the metabolic syndrome in males. Cross-sectional analyses of the Aragon workers health study baseline

  • Saravia, G.
  • Civeira, F.
  • Hurtado-Roca, Y.
  • Andres, E.
  • Leon, M.
  • Pocovi, M.
  • Ordovas, J.
  • Guallar, E.
  • Fernandez-Ortiz, A.
  • Casasnovas, J.A.
  • Laclaustra, M.
Background and aims: Glycated hemoglobin (HbA1c) is currently used to diagnose diabetes mellitus, while insulin has been relegated to research. Both, however, may help understanding the metabolic syndrome and profiling patients. We examined the association of HbA1c and fasting insulin with clustering of metabolic syndrome criteria and insulin resistance as two essential characteristics of the metabolic syndrome. Methods: We used baseline data from 3200 non-diabetic male participants in the Aragon Workers' Health Study. We conducted analysis to estimate age-adjusted odds ratios (ORs) across tertiles of HbA1c and insulin. Fasting glucose and Homeostatic model assessment - Insulin Resistance were used as reference. Here we report the uppermost-to-lowest tertile ORs (95%CI). Results: Mean age (SD) was 48.5 (8.8) years and 23% of participants had metabolic syndrome. The ORs for metabolic syndrome criteria tended to be higher across HbA1c than across glucose, except for high blood pressure. Insulin was associated with the criteria more strongly than HbA1c and similarly to Homeostatic model assessment - Insulin Resistance (HOMA-IR). For metabolic syndrome, the OR of HbA1c was 2.68, of insulin, 11.36, of glucose, 7.03, and of HOMA-IR, 14.40. For the clustering of 2 or more non-glycemic criteria, the OR of HbA1c was 2.10, of insulin, 8.94, of glucose, 1.73, and of HOMA-IR, 7.83. All ORs were statistically significant. The areas under the receiver operating characteristics curves for metabolic syndrome were 0.670 (across HbA1c values) and 0.770 (across insulin values), and, for insulin resistance, 0.647 (HbA1c) and 0.995 (insulin). Among non-metabolic syndrome patients, a small insulin elevation identified risk factor clustering. Conclusions: HbA1c and specially insulin levels were associated with metabolic syndrome criteria, their clustering, and insulin resistance. Insulin could provide early information in subjects prone to develop metabolic syndrome.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families

  • Calvete, O.
  • Martinez, P.
  • Garcia-Pavia, P.
  • Benitez-Buelga, C.
  • Paumard-Hernández, B.
  • Fernandez, V.
  • Dominguez, F.
  • Salas, C.
  • Romero-Laorden, N.
  • Garcia-Donas, J.
  • Carrillo, J.
  • Perona, R.
  • Trivinõ, J.C.
  • Andrés, R.
  • Cano, J.M.
  • Rivera, B.
  • Alonso-Pulpon, L.
  • Setien, F.
  • Esteller, M.
  • Rodriguez-Perales, S.
  • Bougeard, G.
  • Frebourg, T.
  • Urioste, M.
  • Blasco, M.A.
  • Benítez, J.
Cardiac angiosarcoma (CAS) is a rare malignant tumour whose genetic basis is unknown. Here we show, by whole-exome sequencing of a TP53-negative Li-Fraumeni-like (LFL) family including CAS cases, that a missense variant (p.R117C) in POT1 (protection of telomeres 1) gene is responsible for CAS. The same gene alteration is found in two other LFL families with CAS, supporting the causal effect of the identified mutation. We extend the analysis to TP53-negative LFL families with no CAS and find the same mutation in a breast AS family. The mutation is recently found once in 121, 324 studied alleles in ExAC server but it is not described in any other database or found in 1, 520 Spanish controls. In silico structural analysis suggests how the mutation disrupts POT1 structure. Functional and in vitro studies demonstrate that carriers of the mutation show reduced telomere-bound POT1 levels, abnormally long telomeres and increased telomere fragility.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The CoQH2/CoQ Ratio Serves as a Sensor of Respiratory Chain Efficiency

  • Guarás, A.
  • Perales-Clemente, E.
  • Calvo, E.
  • Acín-Pérez, R.
  • Loureiro-Lopez, M.
  • Pujol, C.
  • Martínez-Carrascoso, I.
  • Nuñez, E.
  • García-Marqués, F.
  • Rodríguez-Hernández, M.A.
  • Cortés, A.
  • Diaz, F.
  • Pérez-Martos, A.
  • Moraes, C.T.
  • Fernández-Silva, P.
  • Trifunovic, A.
  • Navas, P.
  • Vazquez, J.
  • Enríquez, J.A.
Electrons feed into the mitochondrial electron transport chain (mETC) from NAD- or FAD-dependent enzymes. A shift from glucose to fatty acids increases electron flux through FAD, which can saturate the oxidation capacity of the dedicated coenzyme Q (CoQ) pool and result in the generation of reactive oxygen species. To prevent this, the mETC superstructure can be reconfigured through the degradation of respiratory complex I, liberating associated complex III to increase electron flux via FAD at the expense of NAD. Here, we demonstrate that this adaptation is driven by the ratio of reduced to oxidized CoQ. Saturation of CoQ oxidation capacity induces reverse electron transport from reduced CoQ to complex I, and the resulting local generation of superoxide oxidizes specific complex I proteins, triggering their degradation and the disintegration of the complex. Thus, CoQ redox status acts as a metabolic sensor that fine-tunes mETC configuration in order to match the prevailing substrate profile.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Role of Mitochondrial Complex IV in Age-Dependent Obesity

  • Soro-Arnaiz, I.
  • Li, Q.O.Y.
  • Torres-Capelli, M.
  • Meléndez-Rodríguez, F.
  • Veiga, S.
  • Veys, K.
  • Sebastian, D.
  • Elorza, A.
  • Tello, D.
  • Hernansanz-Agustín, P.
  • Cogliati, S.
  • Moreno-Navarrete, J.
  • Balsa, E.
  • Fuertes, E.
  • Romanos, E.
  • Martínez-Ruiz, A.
  • Enriquez, J.A.
  • Fernandez-Real, J.
  • Zorzano, A.
  • De Bock, K.
  • Aragonés, J.
Aging is associated with progressive white adipose tissue (WAT) enlargement initiated early in life, but the molecular mechanisms involved remain unknown. Here we show that mitochondrial complex IV (CIV) activity and assembly are already repressed in white adipocytes of middle-aged mice and involve a HIF1A-dependent decline of essential CIV components such as COX5B. At the molecular level, HIF1A binds to the Cox5b proximal promoter and represses its expression. Silencing of Cox5b decreased fatty acid oxidation and promoted intracellular lipid accumulation. Moreover, local in vivo Cox5b silencing in WAT of young mice increased the size of adipocytes, whereas restoration of COX5B expression in aging mice counteracted adipocyte enlargement. An age-dependent reduction in COX5B gene expression was also found in human visceral adipose tissue. Collectively, our findings establish a pivotal role for CIV dysfunction in progressive white adipocyte enlargement during aging, which can be restored to alleviate age-dependent WAT expansion.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival

  • Rabjerg, M.
  • Oliván-Viguera, A.
  • Hansen, L.K.
  • Jensen, L.
  • Sevelsted-Møller, L.
  • Walter, S.
  • Jensen, B.L.
  • Marcussen, N.
  • Köhler, R.
Background Ca2+-activated K+ channels have been implicated in cancer cell growth, metastasis, and tumor angiogenesis. Here we hypothesized that high mRNA and protein expression of the intermediate-conductance Ca2+-activated K+ channel, KCa3.1, is a molecular marker of clear cell Renal Cell Carcinoma (ccRCC) and metastatic potential and survival. Methodology/Principal Findings We analyzed channel expression by qRT-PCR, immunohistochemistry, and patch-clamp in ccRCC and benign oncocytoma specimens, in primary ccRCC and oncocytoma cell lines, as well as in two ccRCC cell lines (Caki-1 and Caki-2). CcRCC specimens contained 12-fold higher mRNA levels of KCa3.1 than oncocytoma specimens. The large-conductance channel, KCa1.1, was 3-fold more highly expressed in ccRCC than in oncocytoma. KCa3.1 mRNA expression in ccRCC was 2-fold higher than in the healthy cortex of the same kidney. Disease specific survival trended towards reduction in the subgroup of high-KCa3.1-expressing tumors (p<0.08 vs. low-KCa3.1-expressing tumors). Progression-free survival (time to metastasis/recurrence) was reduced significantly in the subgroup of high-KCa3.1-expressing tumors (p<0.02, vs. low-KCa3.1-expressing tumors). Immunohistochemistry revealed high protein expression of KCa3.1 in tumor vessels of ccRCC and oncocytoma and in a subset of ccRCC cells. Oncocytoma cells were devoid of KCa3.1 protein. In a primary ccRCC cell line and Caki-1/2-ccRCC cells, we found KCa3.1-protein as well as TRAM-34-sensitive KCa3.1-currents in a subset of cells. Furthermore, Caki-1/2-ccRCC cells displayed functional Paxilline-sensitive KCa1.1 currents. Neither KCa3.1 nor KCa1.1 were found in a primary oncocytoma cell line. Yet KCa-blockers, like TRAM-34 (KCa3.1) and Paxilline (KCa1.1), had no appreciable effects on Caki-1 proliferation in-vitro. Conclusions/Significance Our study demonstrated expression of KCa3.1 in ccRCC but not in benign oncocytoma. Moreover, high KCa3.1-mRNA expression levels were indicative of low disease specific survival of ccRCC patients, short progression-free survival, and a high metastatic potential. Therefore, KCa3.1 is of prognostic value in ccRCC.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Tungstate-targeting of BKaß1 channels tunes ERK phosphorylation and cell proliferation in human vascular smooth muscle

  • Fernández-Mariño, A.I.
  • Cidad, P.
  • Zafra, D.
  • Nocito, L.
  • Domínguez, J.
  • Oliván-Viguera, A.
  • Köhler, R.
  • López-López, J.R.
  • Pérez-García, M.T.
  • Valverde, M.Á.
  • Guinovart, J.J.
  • Fernández-Fernández, J.M.
Despite the substantial knowledge on the antidiabetic, antiobesity and antihypertensive actions of tungstate, information on its primary target/s is scarce. Tungstate activates both the ERK1/2 pathway and the vascular voltage- and Ca2+-dependent large-conductance BKaß1 potassium channel, which modulates vascular smooth muscle cell (VSMC) proliferation and function, respectively. Here, we have assessed the possible involvement of BKaß1 channels in the tungstate-induced ERK phosphorylation and its relevance for VSMC proliferation. Western blot analysis in HEK cell lines showed that expression of vascular BKaß1 channels potentiates the tungstate-induced ERK1/2 phosphorylation in a Gi/o protein-dependent manner. Tungstate activated BKaß1 channels upstream of G proteins as channel activation was not altered by the inhibition of G proteins with GDPßS or pertussis toxin. Moreover, analysis of Gi/o protein activation measuring the FRET among heterologously expressed Gi protein subunits suggested that tungstate-targeting of BKaß1 channels promotes G protein activation. Single channel recordings on VSMCs from wild-type and ß1-knockout mice indicated that the presence of the regulatory ß1 subunit was essential for the tungstate-mediated activation of BK channels in VSMCs. Moreover, the specific BK channel blocker iberiotoxin lowered tungstate-induced ERK phosphorylation by 55% and partially reverted (by 51%) the tungstate-produced reduction of platelet-derived growth factor (PDGF)-induced proliferation in human VSMCs. Our observations indicate that tungstate-targeting of BKaß1 channels promotes activation of PTX-sensitive Gi proteins to enhance the tungstate-induced phosphorylation of ERK, and inhibits PDGF-stimulated cell proliferation in human vascular smooth muscle.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits Endothelium-derived hyperpolarization–type relaxation in coronary artery and produces bradycardia in vivo

  • Oliván-Viguera, Aida
  • Valero, Marta Sofía
  • Coleman, Nicole
  • Brown, Brandon M.
  • Laría, Celia
  • Murillo, María Divina
  • Gálvez, José A.
  • Díaz-de-Villegas, María D.
  • Wulff, Heike
  • Badorrey, Ramón
  • Köhler, Ralf
Small/intermediate conductance KCa channels (KCa2/3) are Ca2+/calmodulin regulated K+ channels that produce membrane hyperpolarization and shape neurologic, epithelial, cardiovascular, and immunologic functions. Moreover, they emerged as therapeutic targets to treat cardiovascular disease, chronic inflammation, and some cancers. Here, we aimed to generate a new pharmacophore for negative-gating modulation of KCa2/3 channels. We synthesized a series of mono- and dibenzoates and identified three dibenzoates [1,3-phenylenebis(methylene) bis(3-fluoro-4-hydroxybenzoate) (RA-2), 1,2-phenylenebis(methylene) bis(3-fluoro-4-hydroxybenzoate), and 1,4-phenylenebis(methylene) bis(3-fluoro-4-hydroxybenzoate)] with inhibitory efficacy as determined by patch clamp. Among them, RA-2 was the most drug-like and inhibited human KCa3.1 with an IC50 of 17 nM and all three human KCa2 subtypes with similar potencies. RA-2 at 100 nM right-shifted the KCa3.1 concentration-response curve for Ca2+ activation. The positive-gating modulator naphtho[1,2-d]thiazol-2-ylamine (SKA-31) reversed channel inhibition at nanomolar RA-2 concentrations. RA-2 had no considerable blocking effects on distantly related large-conductance KCa1.1, Kv1.2/1.3, Kv7.4, hERG, or inwardly rectifying K+ channels. In isometric myography on porcine coronary arteries, RA-2 inhibited bradykinin-induced endothelium-derived hyperpolarization (EDH)–type relaxation in U46619-precontracted rings. Blood pressure telemetry in mice showed that intraperitoneal application of RA-2 (=100 mg/kg) did not increase blood pressure or cause gross behavioral deficits. However, RA-2 decreased heart rate by ˜145 beats per minute, which was not seen in KCa3.1-/- mice. In conclusion, we identified the KCa2/3–negative-gating modulator, RA-2, as a new pharmacophore with nanomolar potency. RA-2 may be of use to generate structurally new types of negative-gating modulators that could help to define the physiologic and pathomechanistic roles of KCa2/3 in the vasculature, central nervous system, and during inflammation in vivo.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Frequency of rare mutations and common genetic variations in severe hypertriglyceridemia in the general population of Spain

  • Lamiquiz-Moneo, I.
  • Blanco-Torrecilla, C.
  • Bea, A. M.
  • Mateo-Gallego, R.
  • Pérez-Calahorra, S.
  • Baila-Rueda, L.
  • Cenarro, A.
  • Civeira, F.
  • de Castro-Orós, I.
Background: Hypertriglyceridemia (HTG) is a common complex metabolic trait that results of the accumulation of relatively common genetic variants in combination with other modifier genes and environmental factors resulting in increased plasma triglyceride (TG) levels. The majority of severe primary hypertriglyceridemias is diagnosed in adulthood and their molecular bases have not been fully defined yet. The prevalence of HTG is highly variable among populations, possibly caused by differences in environmental factors and genetic background. However, the prevalence of very high TG and the frequency of rare mutations causing HTG in a whole non-selected population have not been previously studied. Methods: The total of 23, 310 subjects over 18 years from a primary care-district in a middle-class area of Zaragoza (Spain) with TG >500 mg/dL were selected to establish HTG prevalence. Those affected of primary HTG were considered for further genetic analisys. The promoters, coding regions and exon-intron boundaries of LPL, LMF1, APOC2, APOA5, APOE and GPIHBP1 genes were sequenced. The frequency of rare variants identified was studied in 90 controls. Results: One hundred ninety-four subjects (1.04 %) had HTG and 90 subjects (46.4 %) met the inclusion criteria for primary HTG. In this subgroup, nine patients (12.3 %) were carriers of 7 rare variants in LPL, LMF1, APOA5, GPIHBP1 or APOE genes. Three of these mutations are described for the first time in this work. The presence of a rare pathogenic mutation did not confer a differential phenotype or a higher family history of HTG. Conclusion: The prevalence of rare mutations in candidate genes in subjects with primary HTG is low. The low frequency of rare mutations, the absence of a more severe phenotype or the dominant transmission of the HTG would not suggest the use of genetic analysis in the clinical practice in this population.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

Bile acid synthesis precursors in subjects with genetic hypercholesterolemia negative for LDLR/APOB/PCSK9/APOE mutations. Association with lipids and carotid atherosclerosis

  • Baila-Rueda, L.
  • Cenarro, A.
  • Lamiquiz-Moneo, I.
  • Mateo-Gallego, R.
  • Bea, A.M.
  • Perez-Calahorra, S.
  • Marco-Benedi, V.
  • Civeira, F.
Some oxysterols are precursors of bile acid synthesis and play an important role in cholesterol homeostasis. However, if they are involved in the pathogeny of genetic hypercholesterolemia has not been previously explored. We have studied non-cholesterol sterol markers of cholesterol synthesis (lanosterol and desmosterol) and oxysterols (7a-hydroxy-4-cholesten-3-one, 24S-hydroxycholesterol and 27-hydroxycholesterol) in 200 affected subjects with primary hypercholesterolemia of genetic origin, negative for mutations in LDLR, APOB, PCSK9 and APOE genes (non-FH GH) and 100 normolipemic controls. All studied oxysterols and cholesterol synthesis markers were significantly higher in affected subjects than controls (P < 0.001). Ratios of oxysterols to total cholesterol were higher in non-FH GH than in controls, although only 24S-hydroxycholesterol showed statistical significance (P < 0.001). Cholesterol synthesis markers had a positive correlation with BMI, triglycerides, cholesterol and apoB in control population. However, these correlations disappeared in non-FH GH with the exception of a weak positive correlation for non-HDL cholesterol and apoB. The same pattern was observed for oxysterols with high positive correlation in controls and absence of correlation for non-FH GH, except non-HDL cholesterol for 24S-hydroxycholesterol and 27-hydroxycholesterol and apoB for 27-hydroxycholesterol. All non-cholesterol sterols had positive correlation among them in patients and in controls. A total of 65 (32.5%) and 35 (17.5%) affected subjects presented values of oxysterols ratios to total cholesterol above the 95th percentile of the normal distribution (24S-hydroxycholesterol and 27-hydroxycholesterol, respectively). Those patients with the highest levels of 24S-hydroxycholesterol associated an increase in the carotid intima media thickness. These results suggest that bile acid metabolism is affected in some patients with primary hypercholesterolemia of genetic origin, negative for mutations in the candidate genes, and may confer a higher cardiovascular risk. Our results confirm that cholesterol synthesis overproduction is a primary defect in non-HF GH and suggest that subjects with non-FH GH show high levels of oxysterols in response to hepatic overproduction of cholesterol.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction

  • Fernandez-Berges, D.
  • Degano, I.R.
  • Fernandez, R.G.
  • Subirana, I.
  • Vila, J.
  • Jimenez-Navarro, M.
  • Perez-Fernandez, S.
  • Roque, M.
  • Bayes-Genis, A.
  • Fernandez-Aviles, F.
  • Mayorga, A.
  • Bertomeu-Gonzalez, V.
  • Sanchis, J.
  • Esteban, M.R.
  • Sanchez-Hidalgo, A.
  • Sanchez-Insa, E.
  • Elorriaga, A.
  • Abu Assi, E.
  • Nunez, A.
  • Ruiz, J.M.G.
  • Valdeolmillos, P.M.
  • Bosch-Portell, D.
  • Lekuona, I.
  • Carrillo-Lopez, A.
  • Zamora, A.
  • Vega-Hernandez, B.
  • Serrano, J.A.
  • Rubert, C.
  • Ruiz-Valdepenas, L.
  • Quintas, L.
  • Rodriguez-Padial, L.
  • Vaquero, J.
  • Martinez Dolz, L.
  • Barrabes, J.A.
  • Sanchez, P.L.
  • Sionis, A.
  • Marti-Almor, J.
  • Elosua, R.
  • Lidon, R.M.
  • Garcia-Dorado, D.
  • Marrugat, J.
Objective: Primary percutaneous coronary intervention (P-PCI) has demonstrated its efficacy in patients with ST segment elevation myocardial infarction (STEMI). However, patients with STEMI >= 75 years receive less P-PCI than younger patients despite their higher in-hospital morbimortality. The objective of this analysis was to determine the effectiveness of P-PCI in patients with STEMI >= 75 years. Methods: We included 979 patients with STEMI >= 75 years, from the ATencion HOspitalaria del Sindrome coronario study, a registry of 8142 consecutive patients with acute coronary syndrome admitted at 31 Spanish hospitals in 2014-2016. We calculated a propensity score (PS) for the indication of P-PCI. Patients that received or not P-PCI were matched by PS. Using logistic regression, we compared the effectiveness of performing P-PCI versus non-performance for the composite primary event, which included death, reinfarction, acute pulmonary oedema or cardiogenic shock during hospitalisation. Results: Of the included patients, 81.5 % received P-PCI. The matching provided two groups of 169 patients with and without P-PCI. Compared with its non-performance, P-PCI presented a composite event OR adjusted by PS of 0.55 (95% CI 0.34 to 0.89). Conclusions: Receiving a P-PCI was significantly associated with a reduced risk of major intrahospital complications in patients with STEMI aged 75 years or older.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE

  • Jarauta, E.
  • Pérez-Ruiz, M. R.
  • Pérez-Calahorra, S.
  • Mateo-Gallego, R.
  • Cenarro, A.
  • Cofán, M.
  • Ros, E.
  • Civeira, F.
  • Tejedor, M. T.
Background: A substantial proportion of individuals clinically diagnosed as familial hypercholesterolemia (FH) do not carry pathogenic mutations in candidate genes. Whether in them the high cholesterol trait is transmitted monogenically has not been studied. Objectives: We assessed the inheritance pattern, penetrance, and expression of high low-density lipoprotein (LDL)-cholesterol (LDLc) in families with genetic hypercholesterolemia (GH) without known causative mutations (non-FH-GH). Methods: The study included probands with a clinical diagnosis of FH and their families attending 2 lipid clinics in Spain. Inclusion criteria for probands were LDLc >95th percentile, triglycerides 90th percentile, >5 points in the Dutch Lipid Clinic Network criteria score, and absence of mutations in LDLR, APOB, PCSK9 or APOE. Eleven FH families with a LDLR mutation were also examined for comparison. Results: We analyzed 49 non-FH-GH probands and 277 first-and second-degree relatives. LDLc was >90th percentile in 37.8% of blood relatives, at concentrations similar to those of probands. LDLc had a normal distribution in non-FH-GH families, in contrast with a bimodal distribution in FH families. When a dominant model was tested, family-based association tests gave much lower heritability values for total cholesterol and LDLc in non-FH-GH (0.39 and 0.32, respectively) than in FH (0.78 and 0.61, respectively). Conclusions: Non-FH-GH families have a milder lipid phenotype than genetically defined FH. The heritage pattern of LDLc in non-FH-GH does not fit with a monogenic disorder. Our findings support the concept that most non-FH-GHs are polygenic hypercholesterolemias.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Energy-restricted, high-protein diets more effectively impact cardiometabolic profile in overweight and obese women than lower-protein diets

  • Mateo-Gallego, R.
  • Marco-Benedí, V.
  • Pérez-Calahorra, S.
  • Bea, A. M.
  • Baila-Rueda, L.
  • Lamiquiz-Moneo, I.
  • de Castro-Orós, I.
  • Cenarro, A.
  • Civeira, F.
Background & aims High-protein energy-restricted diets have demonstrated efficacy in promoting weight loss in overweight and obesity. However, the protein percentage that achieves optimal efficacy and acceptability remains unknown. We sought to assess the effects of three energy-reduced diets with different percentages of calories from protein (20%, 27%, and 35%) on weight loss and lipids. Secondary outcomes included diet acceptability and compliance. Methods Six-month, randomized study included women aged 18–80 years with BMI of 27.5–45 kg/m2 and who were not taking lipid-lowering drugs. We randomly assigned 91 women to one of three calorie-reduced diets with: protein, 20%, 27%, or 35% (80% from animal protein); carbohydrates, 50%, 43%, or 35%; fat, 30%. Dietary intervention involved individual visits with a nutritionist every 2 weeks during the first 3 months. We performed a follow-up visit at 6 months. Results Eighty women aged 44.0 ± 9.08 years with BMI of 37.7 ± 3.39 kg/m2 completed the study. At 3 months, weight loss was -8.16 ± 4.18 kg, -9.66 ± 5.28 kg, and -10.7 ± 4.28 kg in the 20%, 27%, and 35%-protein groups, respectively (P = 0.16). These figures slightly and homogeneously increased at 6 months. Around 65% of women following 35%-protein diet lost =10% of body weight vs. ~33% in 20%-protein group (P = 0.023). Significant decreases occurred in fat mass, lipids and insulin resistance, especially in the 35%-protein group (P < 0.05 vs. 20% protein). This improvement was not fully explained by weight loss. Triglyceride change was negatively correlated with animal-protein intake. All groups provided similar responses to an acceptance, palatability, and satisfaction questionnaire. Conclusions An energy-restricted diet with 35% protein, mostly of animal origin, more effectively impacts cardiometabolic profile than an energy-restricted diet with lower protein content although no clear benefit between diets in terms of overall weight loss was observed. The high-protein diet displayed an excellent safety profile and acceptability. This trial was registered in ClinicalTrials.gov as NCT02160496. Clinical trial registration The clinical trial has been registered in ClinicalTrials.gov (Identifier: NCT02160496).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Serum plant sterols as surrogate markers of dietary compliance infamilial dyslipidemias

  • Mateo-Gallego, R.
  • Baila-Rueda, L.
  • Mouratidou, T.
  • De Castro-Orós, I.
  • Bea, A. M.
  • Pérez-Calahorra, S.
  • Cenarro, A.
  • Moreno, L. A.
  • Civeira, F.
Background & aims: A well-balanced diet is the first-line treatment in hyperlipidemia. The objective was to study the association between serum phytosterols and dietary patterns to use them as surrogate markers of dietary compliance in primary dyslipidemias. Methods: 288 patients with primary hyperlipidemias (192 autosomal dominant hypercholesterolemia (ADH) and 96 familial combined hyperlipidemia (FCHL)) were included. Principal factor analysis identified 2 major dietary patterns using a 137-item food frequency questionnaire. “Vegetable & Fruits pattern” was characterized by higher intake of fruits, green beans, nuts, tomatoes, roasted or boiled potatoes, lettuce and chard and lower of processed baked goods, pizza and beer. “Western pattern” was positively characterized by hamburgers, pasta, sunflower oil, rice, chickpeas, whole milk, veal, red beans and negatively with white fish. Serum non-cholesterol sterols were determined by HPLC-MS/MS. Results: Plant sterols to-total cholesterol (TC) levels were lower with a higher adherence to a “Vegetable & Fruits pattern” (P = 0.009), mainly in ADH subjects (R2 = 0.019). Their concentration was greater with higher compliance to “Western pattern” especially in FCHL (P = 0.014). Higher levels of synthesis markers-to-TC with a greater adherence to “Vegetable & Fruits pattern” were found (P = 0.001) (R2 = 0.033 and R2 = 0.109 in ADH and FCHL respectively). Conclusion: In subjects with primary dislipidemia, dietary patterns associate with serum absorption and synthesis markers, but no with lipid concentrations. The influence of diet on non-cholesterol sterols levels is not powerful enough to use them as subrogate markers.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship

  • Sánchez-Hernández, R. M.
  • Civeira, F.
  • Stef, M.
  • Perez-Calahorra, S.
  • Almagro, F.
  • Plana, N.
  • Novoa, F. J.
  • Sáenz-Aranzubía, P.
  • Mosquera, D.
  • Soler, C.
  • Fuentes, F. J.
  • Brito-Casillas, Y.
  • Real, J. T.
  • Blanco-Vaca, F.
  • Ascaso, J. F.
  • Pocovi, M.
Background-Homozygous familial hypercholesterolemia (HoFH) is a rare disease characterized by elevated plasma levels of low-density lipoprotein cholesterol (LDL-C) and extremely high risk of premature atherosclerotic cardiovascular disease. HoFH is caused by mutations in several genes, including LDL receptor (LDLR), apolipoprotein B (APOB), proprotein convertase subtilisin/kexin type 9 (PCSK9), and LDL protein receptor adaptor 1 (LDLRAP1). No epidemiological studies have assessed HoFH prevalence or the clinical and molecular characteristics of this condition. Here, we aimed to characterize HoFH in Spain. Methods and Results-Data were collected from the Spanish Dyslipidemia Registry of the Spanish Atherosclerosis Society and from all molecular diagnoses performed for familial hypercholesterolemia in Spain between 1996 and 2015 (n=16 751). Clinical data included baseline lipid levels and atherosclerotic cardiovascular disease events. A total of 97 subjects were identified as having HoFH-of whom, 47 were true homozygous (1 for APOB, 5 for LDLRAP1, and 41 for LDLR), 45 compound heterozygous for LDLR, 3 double heterozygous for LDLR and PSCK9, and 2 double heterozygous for LDLR and APOB. No PSCK9 homozygous cases were identified. Two variants in LDLR were identified in 4.8% of the molecular studies. Over 50% of patients did not meet the classical HoFH diagnosis criteria. The estimated HoFH prevalence was 1:450 000. Compared with compound heterozygous cases, true homozygous cases showed more aggressive phenotypes with higher LDL-C and more atherosclerotic cardiovascular disease events. Conclusions-HoFH frequency in Spain was higher than expected. Clinical criteria would underestimate the actual prevalence of individuals with genetic HoFH, highlighting the importance of genetic analysis to improve familial hypercholesterolemia diagnosis accuracy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Over-expression of neuron-derived orphan receptor-1 (NOR-1) exacerbates neointimal hyperplasia after vascular injury

  • Rodríguez-Calvo, R.
  • Guadall, A.
  • Calvayrac, O.
  • Navarro, M. A.
  • Alonso, J.
  • Ferrán, B.
  • De Diego, A.
  • Muniesa, P.
  • Osada, J.
  • Rodríguez, C.
  • Martínez-González, J.
We have previously shown that NOR-1 (NR4A3) modulates the proliferation and survival of vascular cells in culture. However, in genetically modified animal models, somewhat conflicting results have been reported concerning the involvement of NOR-1 in neointimal formation after vascular injury. The aim of this study was to generate a transgenic mouse model over-expressing NOR-1 in smooth muscle cells (SMCs) and assess the consequence of a gain of function of this receptor on intimal hyperplasia after vascular injury. The transgene construct (SM22-NOR1) was prepared by ligating the full-length human NOR-1 cDNA (hNOR-1) and a mouse SM22a minimal promoter able to drive NOR-1 expression to SMC. Two founders were generated and two stable transgenic mouse lines (TgNOR-1) were established by backcrossing the transgene-carrying founders with C57BL/6J mice. Real-time PCR and immunohistochemistry confirmed that hNOR-1 was mainly targeted to vascular beds such as aorta and carotid arteries, and was similar in both transgenic lines. Vascular SMC from transgenic animals exhibit increased NOR-1 transcriptional activity (assessed by electrophoretic mobility shift assay and luciferase assays), increased mitogenic activity (deter- mined by [3H]-thymidine incorporation; 1.58-fold induction, P < 0.001) and increased expression of embryonic smooth muscle myosin heavy chain (SMemb) than wild-type cells from control littermates. Using the carotid artery ligation model, we show that neointima formation was increased in transgenic versus wild-type mice (2.36-fold induction, P < 0.01). Our in vivo data support a role for NOR-1 in VSMC proliferation and vascular remodelling. This NOR-1 transgenic mouse could be a useful model to study fibroproliferative vascular diseases.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Asociación de la presencia de placa carotídea en la aparición de eventos cardiovasculares en pacientes con hipercolesterolemias genéticas [Association Between the Presence of Carotid Artery Plaque and Cardiovascular Events in Patients With Genetic Hypercholesterolemia]

  • Bea, Ana M.
  • Civeira, Fernando
  • Jarauta, Estíbaliz
  • Lamiquiz-Moneo, Itziar.
  • Pérez-Calahorra, Sofía
  • Marco-Benedí, Victoria
  • Cenarro, Ana
  • Mateo-Gallego, Rocío
Introduction and objectives The equations used in the general population to calculate cardiovascular risk are not useful in genetic hypercholesterolemia (GH). Carotid plaque detection has proved useful in cardiovascular prediction and risk reclassification but there have been no studies of its usefulness in GH. The aim of this study was to determine the association between the presence of carotid artery plaque and the occurrence of cardiovascular events in patients with GH. Methods This study included 1778 persons with GH. The mean follow-up until the occurrence of cardiovascular events was 6.26 years. At presentation, the presence of carotid artery plaque was studied by high-resolution ultrasound. Results Carotid artery plaque was found in 661 (37.2%) patients: 31.9% with familial hypercholesterolemia, 39.8% with familial combined hyperlipidemia, 45.5% with dysbetalipoproteinemia, and 43.2% with polygenic hypercholesterolemia. During follow-up, 58 patients had a cardiovascular event. Event rates were 6354/100 000 (95%CI, 4432.4-8275.6) in the group with plaque and 1432/100 000 (95%CI, 730.6-2134.3) in the group without plaque, with significant differences between the 2 groups (P <.001). The relative risk of an event was 4.34 (95CI%, 2.44-7.71; P <.001) times higher in patients with plaque and was 2.40 (95%CI, 1.27-4.56; P =.007) times higher after adjustment for major risk factors. The number of carotid artery plaques was positively associated with the risk of cardiovascular events. Conclusions Most cardiovascular events occur in a subgroup of patients who can be identified by carotid plaque detection. These results support the use of plaque screening in this population and should help in risk stratification and treatment in GH. Full English text available from: www.revespcardiol.org/en
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Peroxynitrite formed during a transient episode of brain ischemia increases endothelium-derived hyperpolarization-type dilations in thromboxane/prostaglandin receptor-stimulated rat cerebral arteries

  • Onetti Vilalta, Yara
  • Dantas, A. P.|||0000-0001-8514-4094
  • Pérez, Belén|||0000-0001-5801-1704
  • McNeish, Alister J.
  • Vila Calsina, Elisabet|||0000-0001-8817-9399
  • Jiménez Altayó, Francesc|||0000-0002-9034-2041
AIM: Increased thromboxane A2 and peroxynitrite are hallmarks of cerebral ischaemia/reperfusion (I/R). Stimulation of thromboxane/prostaglandin receptors (TP) attenuates endothelium-derived hyperpolarization (EDH). We investigated whether EDH-type middle cerebral artery (MCA) relaxations following TP stimulation are altered after I/R and the influence of peroxynitrite. METHODS: Vascular function was determined by wire myography after TP stimulation with the thromboxane A2 mimetic 9,11-dideoxy-9α, 11α -methano-epoxy prostaglandin F2α (U46619) in MCA of Sprague Dawley rats subjected to MCA occlusion (90 min)/reperfusion (24 h) or sham operation, and in non-operated (control) rats. Some rats were treated with saline or the peroxynitrite decomposition catalyst 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron (III) (20 mg kg-1 ). Protein expression was evaluated in MCA and in human microvascular endothelial cells submitted to hypoxia (overnight)/reoxygenation (24 h) (H/R) using immunofluorescence and immunoblotting. RESULTS: In U46619-pre-constricted MCA, EDH-type relaxation by the proteinase-activated receptor 2 agonist serine-leucine-isoleucine-glycine-arginine-leucine-NH2 (SLIGRL) was greater in I/R than sham rats due to an increased contribution of small-conductance calcium-activated potassium channels (SKCa ), which was confirmed by the enlarged relaxation to the SKCa activator N-cyclohexyl-N-2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine. I/R and H/R induced endothelial protein tyrosine nitration and filamentous-actin disruption. In control MCA, either cytochalasin D or peroxynitrite disrupted endothelial filamentous-actin and augmented EDH-type relaxation. Furthermore, peroxynitrite decomposition during I/R prevented the increase in EDH-type responses. CONCLUSION: Following TP stimulation in MCA, EDH-type relaxation to SLIGRL is greater after I/R due to endothelial filamentous-actin disruption by peroxynitrite, which prevents TP-induced block of SKCa input to EDH. These results reveal a novel mechanism whereby peroxynitrite could promote post-ischaemic brain injury.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Weight loss in obese patients with heart failure

  • Zamora, Elisabet|||0000-0001-5317-7481
  • Díez-López, Carles|||0000-0002-3734-4777
  • Lupón, Josep|||0000-0002-5601-9611
  • de Antonio Ferrer, Marta|||0000-0002-4319-797X
  • Domingo, Mar|||0000-0002-2935-1272
  • Santesmases Ejarque, Javier|||0000-0002-1226-1617
  • Troya Saborido, María Isabel
  • Diez-Quevedo, Crisanto|||0000-0002-0705-295X
  • Altimir Losada, Salvador
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
BACKGROUND: In heart failure (HF), weight loss (WL) has been associated with an adverse prognosis whereas obesity has been linked to lower mortality (the obesity paradox). The impact of WL in obese patients with HF is incompletely understood. Our objective was to explore the prevalence of WL and its impact on long-term mortality, with an emphasis on obese patients, in a cohort of patients with chronic HF. METHODS AND RESULTS: Weight at first visit and the 1-year follow-up and vital status after 3 years were assessed in 1000 consecutive ambulatory, chronic HF patients (72.7% men; mean age 65.8±12.1 years). Significant WL was defined as a loss of ≥5% weight between baseline and 1 year. Obesity was defined as body mass index ≥30 kg/m(2) (N=272). Of the 1000 patients included, 170 experienced significant WL during the first year of follow-up. Mortality was significantly higher in patients with significant WL (27.6% versus 15.3%, P 0.001). In univariable Cox regression analysis, patients with significant WL had 2-fold higher mortality (hazard ratio 1.95 [95% CI 1.39-2.72], P 0.001). In multivariable analysis, adjusting for age, sex, body mass index, New York Heart Association functional class, left ventricular ejection fraction, HF duration, ischemic etiology, diabetes, and treatment, significant WL remained independently associated with higher mortality (hazard ratio 1.89 [95% CI 1.32-2.68], P 0.001). Among obese patients with HF, significant WL was associated with an even more ominous prognosis (adjusted hazard ratio for death of 2.38 [95% CI 1.31-4.32], P=0.004) than that observed in nonobese patients (adjusted hazard ratio 1.83 [95% CI 1.16-2.89], P=0.01). CONCLUSIONS: Weight loss ≥5% in patients with chronic HF was associated with high long-term mortality, particularly among obese patients with HF.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lymphocyte Activation Dynamics Is Shaped by Hereditary Components at Chromosome Region 17q12-q21

  • Carreras Sureda, Amado
  • Rubio Moscardo, Fanny
  • Olvera, Alex|||0000-0002-9934-5759
  • Argilaguet, Jordi|||0000-0001-5924-2774
  • Kiefer, Kerstin
  • Mothe, Beatriz|||0000-0001-9975-407X
  • Meyerhans, Andreas|||0000-0003-0620-5317
  • Brander, Christian|||0000-0002-0548-5778
  • Vicente, Rubén|||0000-0003-0401-4808
Single nucleotide polymorphisms (SNPs) located in the chromosome region 17q12-q21 are risk factors for asthma. Particularly, there are cis-regulatory haplotypes within this region that regulate differentially the expression levels of ORMDL3, GSDMB and ZPBP2 genes. Remarkably, ORMDL3 has been shown to modulate lymphocyte activation parameters in a heterologous expression system. In this context, it has been shown that Th2 and Th17 cytokine production is affected by SNPs in this region. Therefore, we aim to assess the impact of hereditary components within region 17q12-q21 on the activation profile of human T lymphocytes, focusing on the haplotype formed by allelic variants of SNPs rs7216389 and rs12936231. We measured calcium influx and activation markers, as well as the proliferation rate upon T cell activation. Haplotype-dependent differences in mRNA expression levels of IL-2 and INF-γ were observed at early times after activation. In addition, the allelic variants of these SNPs impacted on the extent of calcium influx in resting lymphocytes and altered proliferation rates in a dose dependent manner. As a result, the asthma risk haplotype carriers showed a lower threshold of saturation during activation. Finally, we confirmed differences in activation marker expression by flow cytometry using phytohemagglutinin, a strong polyclonal stimulus. Altogether, our data suggest that the genetic component of pro-inflammatory pathologies present in this chromosome region could be explained by different T lymphocyte activation dynamics depending on individual allelic heredity.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Single Intracoronary Injection of Encapsulated Antagomir-92a Promotes Angiogenesis and Prevents Adverse Infarct Remodeling

  • Bellera Gotarda, Neus|||0000-0002-1040-0900
  • Barba, Ignasi|||0000-0001-9886-3776
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • Ferret, Eulalia
  • Asín, Miguel Angel
  • Gonzalez-Alujas, MªTeresa
  • Pérez-Rodón, Jordi|||0000-0003-2234-5248
  • Esteves, Marielle
  • Fonseca, Carla
  • Toran, Nuria
  • García del Blanco, Bruno|||0000-0002-4527-1600
  • Pérez, Amadeo
  • García-Dorado, David|||0000-0002-1126-1279
Small and large preclinical animal models have shown that antagomir-92a-based therapy reduces early postischemic loss of function, but its effect on postinfarction remodeling is not known. In addition, the reported remote miR-92a inhibition in noncardiac organs prevents the translation of nonvectorized miR-targeted therapy to the clinical setting. We investigated whether a single intracoronary administration of antagomir-92a encapsulated in microspheres could prevent deleterious remodeling of myocardium 1 month after acute myocardial infarction AUTHOR: Should "acute" be added before "myocardial infarction" (since abbreviation is AMI)? Also check at first mention in main text (AMI) without adverse effects. In a percutaneous pig model of reperfused AMI, a single intracoronary administration of antagomir-92a encapsulated in specific microspheres (9 μm poly-d,-lactide-co-glycolide [PLGA]) inhibited miR-92a in a local, selective, and sustained manner (n=3 pigs euthanized 1, 3, and 10 days after treatment; 8×, 2×, and 5×-fold inhibition at 1, 3, and 10 days). Downregulation of miR-92a resulted in significant vessel growth (n=27 adult minipigs randomly allocated to blind receive encapsulated antagomir-92a, encapsulated placebo, or saline [n=8, 9, 9]; P =0.001), reduced regional wall-motion dysfunction (P =0.03), and prevented adverse remodeling in the infarct area 1 month after injury (P =0.03). Intracoronary injection of microspheres had no significant adverse effect in downstream myocardium in healthy pigs (n=2), and fluorescein isothiocyanate albumin-PLGA microspheres were not found in myocardium outside the left anterior descending coronary artery territory (n=4) or in other organs (n=2). Early single intracoronary administration of encapsulated antagomir-92a in an adult pig model of reperfused AMI prevents left ventricular remodeling with no local or distant adverse effects, emerging as a promising therapeutic approach to translate to patients who suffer a large AMI.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Defective sarcoplasmic reticulum-mitochondria calcium exchange in aged mouse myocardium

  • Fernández Sanz, Celia
  • Ruiz-Meana, M.
  • Miró-Casas, Elisabet|||0000-0002-2058-5961
  • Nuñez, E.
  • Castellano, J.
  • Loureiro, M.
  • Barba, Ignasi|||0000-0001-9886-3776
  • Poncelas, M.
  • Rodriguez-Sinovas, A.
  • Vázquez, Jesús|||0000-0003-1461-5092
  • García-Dorado, David|||0000-0002-1126-1279
Mitochondrial alterations are critically involved in increased vulnerability to disease during aging. We investigated the contribution of mitochondria-sarcoplasmic reticulum (SR) communication in cardiomyocyte functional alterations during aging. Heart function (echocardiography) and ATP/phosphocreatine (NMR spectroscopy) were preserved in hearts from old mice (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Ischemia/reperfusion activates myocardial innate immune response, the key role of the toll-like receptor

  • Vilahur, Gemma|||0000-0002-2828-8873
  • Badimon, Lina|||0000-0002-9162-2459
Recent data have indicated that the myocardium may act as an immune organ initiating cardiac innate immune response and inflammation. It has been suggested that activation of the immune system occurs upon the interaction of damage-associated molecular patterns (DAMPs) generated and released during ischemic damage with pattern recognition receptors (Toll like receptors; TLR) present in cardiac cells. Among TLRs, TLR4, and TLR2 are the ones mostly expressed in cardiac tissue. Whereas TLR4 has shown to play a detrimental role in myocardial ischemia/reperfusion (I/R) injury, the effect elicited by TLR2 activation remains controversial. Once activated, TLR signaling may occur via the Myd88- and Trif- dependent pathways leading to NFκB and IFN-3 activation, respectively, and subsequent stimulation of pro-inflammatory and immunomodulatory cytokine gene expression. Cytokine release contributes to neutrophils activation, recruitment, adhesion and infiltration to the site of cardiac injury further perpetuating the inflammatory process. This mini-review will focus on the current knowledge regarding the role of the heart in inducing and coordinating the innate inflammatory response via the TLR signaling pathway in myocardial I/R injury.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Ageing is associated with deterioration of calcium homeostasis in isolated human right atrial myocytes

  • Herraiz-Martínez, Adela
  • Alvarez-Garcia, Jesus|||0000-0002-2015-6446
  • Llach, Anna|||0000-0002-7486-1079
  • Molina, Cristina E.|||0000-0003-3094-1568
  • Fernandes, Jacqueline
  • Ferrero-Gregori, Andreu|||0000-0001-6492-2416
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Vallmitjana, Alexander
  • Benítez, Raúl|||0000-0002-8782-9406
  • Padró Fernández, Josep Maria|||0000-0003-3464-6689
  • Martínez-González, José|||0000-0002-3894-7166
  • Cinca, Juan|||0000-0003-4819-4265
  • Madsen, Leif Hove|||0000-0001-5493-3998
Ageing-related cardiac disorders such as heart failure and atrial fibrillation often present with intracellular calcium homeostasis dysfunction. However, knowledge of the intrinsic effects of ageing on cellular calcium handling in the human heart is sparse. Therefore, this study aimed to analyse how ageing affects key mechanisms that regulate intracellular calcium in human atrial myocytes. Whole membrane currents and intracellular calcium transients were measured in isolated human right atrial myocytes from 80 patients with normal left atrial dimensions and no history of atrial fibrillation. Patients were categorized as young (<55 years, n = 21), middle aged (55-74 years, n = 42), and old (≥75 years, n = 17). Protein levels were determined by western blot. Ageing was associated with the following electrophysiological changes: (i) a 3.2-fold decrease in the calcium transient (P < 0.01); (ii) reduction of the L-type calcium current (I ) amplitude (2.4 ± 0.3 pA/pF vs. 1.4 ± 0.2 pA/pF, P < 0.01); (iii) lower levels of L-type calcium channel alpha-subunit (P < 0.05); (iv) lower rates of both fast (14.5 ± 0.9 ms vs. 20.9 ± 1.9, P < 0.01) and slow (73 ± 3 vs. 120 ± 12 ms, P < 0.001) I inactivation; and (v) a decrease in the sarcoplasmic reticulum calcium content (10.1 ± 0.8 vs. 6.4 ± 0.6 amol/pF, P < 0.005) associated with a significant decrease in both SERCA2 (P < 0.05) and calsequestrin-2 (P < 0.05) protein levels. In contrast, ageing did not affect spontaneous sarcoplasmic reticulum calcium release. Ageing is associated with depression of SR calcium content, L-type calcium current, and calcium transient amplitude that may favour a progressive decline in right atrial contractile function with age.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma

  • León i Vintró, Xavier|||0000-0001-6286-630X
  • Bothe González, Carolina
  • García Lorenzo, Jacinto
  • Parreño, Matilde
  • Alcolea, Sonia
  • Quer, Miquel|||0000-0003-2563-6729
  • Vila Navarro, Luis
  • Camacho, Mercedes|||0000-0001-5970-3294
The presence of IL-1 in human cancers is associated with aggressive tumor biology but its prognostic value is unknown. We studied whether IL-1α expression is a prognostic marker of distant metastasis in patients with head and neck squamous cell carcinoma (HNSCC). IL-1α mRNA and protein levels were determined in tumor samples and cancer cell lines using RT-PCR and ELISA. The effects of constitutive IL-1α expression by tumor lines were characterized. IL-1α mRNA and protein secretion were higher in tumor samples from patients who later developed distant metastasis than in patients who did not. By using distant metastasis as a dependent variable, patients were classified into two categories of IL-1α transcript-levels. The high-IL-1α group had a significantly lower five-year distant metastasis-free survival than the low-IL-1α group [70.0% (CI 95%: 55.9-84.1%) vs 94.7% (CI 95%:90.2-99.2%)]. When IL-1α transcript-levels were combined with clinical factors related to tumor metastasis, the predictive power of the model increased significantly. Additionally, transcript levels of IL-1α correlated significantly with those of the IL-1 family genes and genes related to the metastatic process. IL-1 treatment of microvascular endothelial cells increased adhesion of HNSCC cells but no differences were found based on constitutive IL-1α expression by tumor cells. Nevertheless, IL-1α produced by tumor cells effectively increased their transmigration across the endothelium. We found a significant relationship between IL-1α expression and development of distant metastasis in HNSCC patients. IL-1α expression could help to define a subset of patients at high risk of distant metastasis who could benefit from adjuvant treatment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia, between bench and bedside

  • Cabrera-Fuentes, H. A.|||0000-0002-8502-7098
  • Alba-Alba, Corina
  • Aragones, Julian
  • Bernhagen, Jürgen
  • Boisvert, William A.
  • Bøtker, Hans Erik|||0000-0001-6358-8962
  • Cesarman-Maus, Gabriela
  • Fleming, Ingrid
  • García-Dorado, David|||0000-0002-1126-1279
  • Lecour, Sandrine|||0000-0003-1942-8974
  • Liehn, Elisa
  • Marber, Michael S.
  • Marina, Nephtali
  • Mayr, Manuel
  • Perez-Mendez, Oscar
  • Miura, Tetsuji|||0000-0001-5024-7085
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Salinas-Estefanon, Eduardo M.
  • Ong, Sang-Bing
  • Schnittler, Hans J.
  • Sanchez-Vega, Jose T.
  • Sumoza-Toledo, Adriana
  • Vogel, Carl-Wilhelm
  • Yarullina, Dina
  • Yellon, Derek|||0000-0001-7791-9320
  • Preissner, Klaus T.
  • Hausenloy, Derek J.
Recent advances in basic cardiovascular research as well as their translation into the clinical situation were the focus at the last "New Frontiers in Cardiovascular Research meeting". Major topics included the characterization of new targets and procedures in cardioprotection, deciphering new players and inflammatory mechanisms in ischemic heart disease as well as uncovering microRNAs and other biomarkers as versatile and possibly causal factors in cardiovascular pathogenesis. Although a number of pathological situations such as ischemia-reperfusion injury or atherosclerosis can be simulated and manipulated in diverse animal models, also to challenge new drugs for intervention, patient studies are the ultimate litmus test to obtain unequivocal information about the validity of biomedical concepts and their application in the clinics. Thus, the open and bidirectional exchange between bench and bedside is crucial to advance the field of ischemic heart disease with a particular emphasis of understanding long-lasting approaches in cardioprotection.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Hospital and 4-year mortality predictors in patients with acute pulmonary edema with and without coronary artery disease

  • Figueras Bellot, Jaime
  • Bañeras, Jordi|||0000-0002-7395-0862
  • Peña-Gil, Carlos
  • Barrabés, José A.|||0000-0001-7062-6277
  • Rodríguez Palomares, José Fernando|||0000-0002-8822-5532
  • García-Dorado, David|||0000-0002-1126-1279
Long-term prognosis of acute pulmonary edema () remains ill defined. We evaluated demographic, echocardiographic, and angiographic data of 806 consecutive patients with with () and without coronary artery disease (non-) admitted from 2000 to 2010. Differences between hospital and long-term mortality and its predictors were also assessed. patients (n=638) were older and had higher incidence of diabetes and peripheral vascular disease than non- (n=168), and lower ejection fraction. Hospital mortality was similar in both groups (26.5% vs 31.5%; P =0.169) but recurrence was higher in patients (17.3% vs 6.5%; P <0.001). Age, admission systolic blood pressure, recurrence of , and need for inotropics or endotracheal intubation were the main independent predictors of hospital mortality. In contrast, overall mortality (70.0% vs 57.1%; P =0.002) and readmission for nonfatal heart failure after a 45-month follow-up (10-140; 17.3% vs 7.6%; P =0.009) were higher in than in non- patients. Age, peripheral vascular disease, and peak creatine kinase during index hospitalization, but not ejection fraction, were the main independent predictors of overall mortality, whereas coronary revascularization or valvular surgery were protective. These interventions were mostly performed during hospitalization index (294 of 307; 96%) and not intervened patients showed a higher risk profile. Long-term mortality in is high and higher in than in non- patients. Considering the different in-hospital and long-term mortality predictors herein described, which do not necessarily involve systolic function, it is conceivable that a more aggressive interventional program might improve survival in high-risk patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

New protein-protein interactions of mitochondrial connexin 43 in mouse heart

  • Denuc, Amanda
  • Nuñez, Estefania|||0000-0002-0876-1264
  • Calvo, Enrique
  • Loureiro, Marta
  • Miró-Casas, Elisabet|||0000-0002-2058-5961
  • Guarás, Adela
  • Vázquez, Jesús|||0000-0003-1461-5092
  • García-Dorado, David|||0000-0002-1126-1279
Connexin 43 (Cx43), the gap junction protein involved in cell-to-cell coupling in the heart, is also present in the subsarcolemmal fraction of cardiomyocyte mitochondria. It has been described to regulate mitochondrial potassium influx and respiration and to be important for ischaemic preconditioning protection, although the molecular effectors involved are not fully characterized. In this study, we looked for potential partners of mitochondrial Cx43 in an attempt to identify new molecular pathways for cardioprotection. Mass spectrometry analysis of native immunoprecipitated mitochondrial extracts showed that Cx43 interacts with several proteins related with mitochondrial function and metabolism. Among them, we selected for further analysis only those present in the subsarcolemmal mitochondrial fraction and known to be related with the respiratory chain. Apoptosis-inducing factor () and the beta-subunit of the electron-transfer protein (), two proteins unrelated to date with Cx43, fulfilled these conditions, and their interaction with Cx43 was proven by direct and reverse co-immunoprecipitation. Furthermore, a previously unknown molecular interaction between and was established, and protein content and sub-cellular localization appeared to be independent from the presence of Cx43. Our results identify new protein-protein interactions between -Cx43, -Cx43 and - as possible players in the regulation of the mitochondrial redox state.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction, trials and tribulations

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Recognition of Fibrotic Infarct Density by the Pattern of Local Systolic-Diastolic Myocardial Electrical Impedance

  • Amorós Figueras, Gerard|||0000-0002-2109-5550
  • Jorge, Esther|||0000-0002-2777-0000
  • García Sánchez, Tomás
  • Bragos, Ramon|||0000-0002-1373-1588
  • Rosell Ferrer, Javier|||0000-0002-9691-328X
  • Cinca, Juan|||0000-0003-4819-4265
Myocardial electrical impedance is a biophysical property of the heart that is influenced by the intrinsic structural characteristics of the tissue. Therefore, the structural derangements elicited in a chronic myocardial infarction should cause specific changes in the local systolic-diastolic myocardial impedance, but this is not known. This study aimed to characterize the local changes of systolic-diastolic myocardial impedance in a healed myocardial infarction model. Six pigs were successfully submitted to 150 min of left anterior descending (LAD) coronary artery occlusion followed by reperfusion. 4 weeks later, myocardial impedance spectroscopy (1-1000 kHz) was measured at different infarction sites. The electrocardiogram, left ventricular (LV) pressure, LV dP/dt, and aortic blood flow (ABF) were also recorded. A total of 59 LV tissue samples were obtained and histopathological studies were performed to quantify the percentage of fibrosis. Samples were categorized as normal myocardium (<10% fibrosis), heterogeneous scar (10-50%) and dense scar (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Multi-Biomarker Profiling and Recurrent Hospitalizations in Heart Failure

  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Núñez, Julio|||0000-0003-1672-7119
  • Núñez, Eduardo
  • Martínez, Jaume Barallat
  • Pastor Ferrer, Maria Cruz
  • de Antonio Ferrer, Marta|||0000-0002-4319-797X
  • Zamora, Elisabet|||0000-0001-5317-7481
  • Sanchis, Juan|||0000-0003-0797-8709
  • Rosés, Josep Lupón
Despite advances in pharmacologic therapy and devices, patients with heart failure (HF) continue to have significant rehospitalization rates and risk prediction remains challenging. We sought to explore the value of a multi-biomarker panel [including NT-proBNP, high-sensitivity cardiac troponin T (hs-TnT), and ST2] on top of clinical assessment for long-term prediction of recurrent hospitalizations in HF. NT-proBNP, hs-TnT, and ST2 (suppression of tumorigenicity-2) levels were measured in 891 consecutive ambulatory HF patients. The independent association between the multi-biomarker panel and recurrent hospitalizations was assessed through a multivariable negative binomial regression and expressed as incidence rates ratios. McFadden pseudo- R 2 and goodness-of-fit measures were also used. The total number of unplanned hospitalizations [all-cause, cardiovascular (CV)-, and HF-related] were selected as the primary endpoints. At a mean follow-up of 4.2 ± 2.1 years, 1623 all-cause hospitalizations in 498 patients (55.9%), 710 CV-related hospitalizations in 331 patients (37.2%), and 444 HF-related hospitalizations in 214 patients (24.1%) were registered. The crude incidence of all-cause, CV-, and HF-related recurrent hospitalizations was significantly higher for patients with the multi-biomarker panel above the cut-point (hs-TnT.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Data on clinical characteristics of a heart failure patients' cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers, high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP

  • Batlle, Montserrat|||0000-0002-3034-2023
  • Campos, B.
  • Farrero, Marta|||0000-0002-2404-8821
  • Cardona, Montserrat
  • González, Beatriz
  • Castel, M. A.
  • Ortiz, Joana|||0000-0002-2236-154X
  • Roig, Eulàlia|||0000-0002-3421-4985
  • Pulgarín, M. J.
  • Ramírez, J.
  • Bedini, Josep L.
  • Sabaté Gallego, Mònica|||0000-0001-6206-1085
  • de Frutos, P. García
  • Pérez-Villa, Félix|||0000-0001-9244-938X
In this article, the full description of a heart failure with reduced ejection fraction (HF_REF) cohort of 192 patients is provided. Tables with the baseline demographic, prior history, ECG parameters, echocardiographic parameters, laboratory values and pharmacological treatment of these patients are included. Also, the quartile values of the analyzed circulating biomarkers: high sensitivity Troponin T (hs-TnT), galectin-3 (Gal-3), C-terminal propeptide of type I procollagen (CICP), soluble AXL (sAXL) and Brain Natriuretic Peptide (BNP) are given. The main demographic and clinical features of the patients' subgroups that have hs-TnT, Gal-3, CICP or BNP above the third quartile are described. Tables with Pearson correlation analysis of the HF_REF patients' biomarker levels are included. And Pearson correlation analysis of the HF_REF patients' hs-TnT, Gal-3, CICP levels with patients' biochemical parameters, blood count and inflammation parameters are also described. These data are related to the research articles (AXL receptor tyrosine kinase is increased in patients with heart failure (M. Batlle, P. Recarte-Pelz, E. Roig, M.A. Castel, M. Cardona, M. Farrero, et al., 2014) [1] and Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in Heart Failure patients with reduced ejection fraction: comparison with soluble AXL and BNP (M. Batlle, B. Campos, M. Farrero, M. Cardona, B. González, M.A. Castel, et al., 2016) [2].
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Ischemic stroke patients are biologically older than their chronological age

  • Soriano Tárraga, Carolina|||0000-0002-5635-273X
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Mola-Caminal, Marina
  • Vivanco-Hidalgo, Rosa Maria|||0000-0001-7547-0291
  • Ois, Angel|||0000-0002-1375-5950
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Sayols-Baixeras, Sergi
  • Elosua, Roberto|||0000-0001-8235-0095
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
Ischemic stroke is associated with aging. It is possible to predict chronological age by measuring age-related changes in DNA methylation from multiple CpG sites across the genome, known as biological age. The difference between biological age and actual chronological age would indicate an individual's level of aging. Our aim was to determine the biological age of ischemic stroke patients and compare their aging with controls of the same chronological age. A total of 123 individuals, 41 controls and 82 patients with ischemic stroke were paired by chronological age, ranging from 39 to 82 years. Illumina HumanMethylation450 BeadChip array was used to measure DNA methylation in CpG sites in both groups, and biological age was estimated using methylation values of specific CpGs. Ischemic stroke patients were biologically an average 2.5 years older than healthy controls (p-value=0.010). Stratified by age tertiles, younger stroke patients (≤57 years old) were biologically older than controls (OR=1.19; 95%CI 1.00-1.41, p-value=0.046). The older groups showed no biological age differences between cases and controls, but were close to reaching the significance level. Ischemic stroke patients are biologically older than controls. Biological age should be considered as a potential new biomarker of stroke risk.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era, beyond myocardial mechanical reperfusion

  • Ribas Barquet, Núria|||0000-0003-1492-5285
  • Garcia Garcia, Cosme|||0000-0001-6330-1677
  • Meroño, Oona
  • Recasens, Lluís
  • Pérez-Fernández, Silvia|||0000-0002-9756-0092
  • Bazán, Víctor|||0000-0001-8072-7434
  • Salvatella, Neus
  • Martí Almor, Julio|||0000-0001-9927-1190
  • Bruguera Cortada, Jordi
  • Elosua, Roberto|||0000-0001-8235-0095
The AMI code is a regional network enhancing a rapid and widespread access to reperfusion therapy (giving priority to primary angioplasty) in patients with acute ST-segment elevation myocardial infarction (STEMI). We aimed to assess the long-term control of conventional cardiovascular risk factors after a STEMI among patients included in the AMI code registry. Four hundred and fifty-four patients were prospectively included between June-2009 and April-2013. Clinical characteristics were collected at baseline. The long-term control of cardiovascular risk factors and cardiovascular morbidity/mortality was assessed among the 6-months survivors. A total of 423 patients overcame the first 6 months after the STEMI episode, of whom 370 (87%) underwent reperfusion therapy (363, 98% of them, with primary angioplasty). At 1-year follow-up, only 263 (62%) had adequate blood pressure control, 123 (29%) had LDL-cholesterol within targeted levels, 126/210 (60%) smokers had withdrawn from their habit and 40/112 (36%) diabetic patients had adequate glycosylated hemoglobin levels. During a median follow-up of 20 (11-30) months, cumulative mortality of 6 month-survivors was 6.1%, with 9.9% of hospital cardiovascular readmissions. The lack of assessment of LDL and HDL-cholesterol were significantly associated with higher mortality and cardiovascular readmission rates. Whereas implementation of the AMI code resulted in a widespread access to rapid reperfusion therapy, its long-term therapeutic benefit may be partially counterbalanced by a manifestly suboptimal control of cardiovascular risk factors. Further efforts should be devoted to secondary prevention strategies after STEMI. The online version of this article (doi:10.1186/s12872-017-0493-6) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Intracoronary Administration of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction

  • Bobi, Joaquim|||0000-0002-9026-5226
  • Solanes, Núria
  • Fernández-Jiménez, Rodrigo
  • Galán-Arriola, Carlos
  • Dantas, A. P.|||0000-0001-8514-4094
  • Fernández-Friera, Leticia
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
  • Rigol-Monzó, Elisabet
  • Agüero, Jaume|||0000-0001-7416-871X
  • Ramírez, José
  • Roqué, Mercè
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Sánchez González, Javier|||0000-0003-1427-3870
  • García-Álvarez, Ana|||0000-0002-1718-2424
  • Sabaté, Manel
  • Rudilla, F..
  • Ibañez, Borja|||0000-0002-5036-254X
  • Rigol, Montserrat
Autologous adipose tissue-derived mesenchymal stem cells (s) therapy is a promising strategy to improve post-myocardial infarction outcomes. In a porcine model of acute myocardial infarction, we studied the long-term effects and the mechanisms involved in allogeneic s administration on myocardial performance. Thirty-eight pigs underwent 50 minutes of coronary occlusion; the study was completed in 33 pigs. After reperfusion, allogeneic s or culture medium (vehicle) were intracoronarily administered. Follow-ups were performed at short (2 days after acute myocardial infarction vehicle-treated, n=10; s-treated, n=9) or long term (60 days after acute myocardial infarction vehicle-treated, n=7; s-treated, n=7). At short term, infarcted myocardium analysis showed reduced apoptosis in the s-treated animals (48.6±6% versus 55.9±5.7% in vehicle; P =0.017); enhancement of the reparative process with up-regulated vascular endothelial growth factor, granulocyte macrophage colony-stimulating factor, and stromal-derived factor-1α gene expression; and increased M2 macrophages (67.2±10% versus 54.7±10.2% in vehicle; P =0.016). In long-term groups, increase in myocardial perfusion at the anterior infarct border was observed both on day-7 and day-60 cardiac magnetic resonance studies in s-treated animals, compared to vehicle (87.9±28.7 versus 57.4±17.7 mL/min per gram at 7 days; P =0.034 and 99±22.6 versus 43.3±14.7 22.6 mL/min per gram at 60 days; P =0.0001, respectively). At day 60, higher vascular density was detected at the border zone in the s-treated animals (118±18 versus 92.4±24.3 vessels/mm 2 in vehicle; P =0.045). Cardiac magnetic resonance-measured left ventricular ejection fraction of left ventricular volumes was not different between groups at any time point. In this porcine acute myocardial infarction model, allogeneic s-based therapy was associated with increased cardioprotective and reparative mechanisms and with better cardiac magnetic resonance-measured perfusion. No effect on left ventricular volumes or ejection fraction was observed.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES), comprehensive genetic analysis by next-generation sequencing of 480 patients

  • Borràs, Nina
  • Batlle, Javier|||0000-0002-7931-2546
  • Pérez-Rodríguez, Almudena
  • López-Fernández, María Fernanda
  • Rodríguez-Trillo, Ángela
  • Lourés, Esther
  • Cid, Ana Rosa
  • Bonanad, Santiago|||0000-0002-8390-8211
  • Cabrera, Noelia
  • Moret, Andrés
  • Parra, Rafael
  • Mingot-Castellano, María Eva|||0000-0001-9083-855X
  • Balda, Ignacia
  • Altisent, Carmen
  • Pérez-Montes, Rocío
  • Fisac, Rosa María
  • Iruín, Gemma
  • Herrero, Sonia
  • Soto, Inmaculada
  • de Rueda, Beatriz
  • Jiménez-Yuste, Víctor|||0000-0003-3937-3499
  • Alonso, Nieves
  • Vilariño, Dolores
  • Arija, Olga
  • Campos, Rosa
  • Paloma, María José
  • Bermejo, Nuria
  • Berrueco, Rubén|||0000-0002-1068-7489
  • Mateo, Jose|||0000-0002-4227-3256
  • Arribalzaga, Karmele
  • Marco, Pascual
  • Palomo Bravo, Ángeles
  • Sarmiento, Lizheidy
  • Iñigo, Belén
  • Nieto Hernández, Maria del Mar
  • Vidal, Rosa
  • Martínez, María Paz
  • Aguinaco, Reyes
  • César, Jesús María
  • Ferreiro, María
  • García-Frade, Javier
  • Rodríguez-Huerta, Ana María
  • Cuesta, Jorge
  • Rodríguez-González, Ramón
  • García-Candel, Faustino|||0000-0002-6369-6004
  • Cornudella, Rosa
  • Aguilar Franco, Carlos
  • Vidal, Francisco|||0000-0001-8089-4945
  • Corrales Insa, Irene|||0000-0002-0647-0340
Molecular diagnosis of patients with von Willebrand disease is pending in most populations due to the complexity and high cost of conventional molecular analyses. The need for molecular and clinical characterization of von Willebrand disease in Spain prompted the creation of a multicenter project (PCM-EVW-ES) that resulted in the largest prospective cohort study of patients with all types of von Willebrand disease. Molecular analysis of relevant regions of the VWF, including intronic and promoter regions, was achieved in the 556 individuals recruited via the development of a simple, innovative, relatively low-cost protocol based on microfluidic technology and next-generation sequencing. A total of 704 variants (237 different) were identified along VWF, 155 of which had not been previously recorded in the international mutation database. The potential pathogenic effect of these variants was assessed by in silico analysis. Furthermore, four short tandem repeats were analyzed in order to evaluate the ancestral origin of recurrent mutations. The outcome of genetic analysis allowed for the reclassification of 110 patients, identification of 37 asymptomatic carriers (important for genetic counseling) and re-inclusion of 43 patients previously excluded by phenotyping results. In total, 480 patients were definitively diagnosed. Candidate mutations were identified in all patients except 13 type 1 von Willebrand disease, yielding a high genotype-phenotype correlation. Our data reinforce the capital importance and usefulness of genetics in von Willebrand disease diagnostics. The progressive implementation of molecular study as the first-line test for routine diagnosis of this condition will lead to increasingly more personalized and effective care for this patient population.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Unravelling the effects of mechanical physiological conditioning on cardiac adipose tissue-derived progenitor cells in vitro and in silico

  • Llucià-Valldeperas, Aida
  • Bragos, Ramon|||0000-0002-1373-1588
  • Soler Botija, Carolina
  • Roura, Santiago|||0000-0003-4063-9661
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
  • Prat-Vidal, Cristina|||0000-0002-5621-1101
  • Perea Gil, Isaac
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
Mechanical conditioning is incompletely characterized for stimulating therapeutic cells within the physiological range. We sought to unravel the mechanism of action underlying mechanical conditioning of adipose tissue-derived progenitor cells (ATDPCs), both in vitro and in silico. Cardiac ATDPCs, grown on 3 different patterned surfaces, were mechanically stretched for 7 days at 1 Hz. A custom-designed, magnet-based, mechanical stimulator device was developed to apply ~10% mechanical stretching to monolayer cell cultures. Gene and protein analyses were performed for each cell type and condition. Cell supernatants were also collected to analyze secreted proteins and construct an artificial neural network. Gene and protein modulations were different for each surface pattern. After mechanostimulation, cardiac ATDPCs increased the expression of structural genes and there was a rising trend on cardiac transcription factors. Finally, secretome analyses revealed upregulation of proteins associated with both myocardial infarction and cardiac regeneration, such as regulators of the immune response, angiogenesis or cell adhesion. To conclude, mechanical conditioning of cardiac ATDPCs enhanced the expression of early and late cardiac genes in vitro. Additionally, in silico analyses of secreted proteins showed that mechanical stimulation of cardiac ATDPCs was highly associated with myocardial infarction and repair.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cardiomyocyte hypertrophy induced by Endonuclease G deficiency requires reactive oxygen radicals accumulation and is inhibitable by the micropeptide humanin

  • Blasco, Natividad
  • Cámara, Yolanda|||0000-0003-2458-6942
  • Nuñez, Estefania|||0000-0002-0876-1264
  • Beà, Aida|||0000-0002-9733-4618
  • Barés, Gisel
  • Forne, Carles|||0000-0002-8133-3274
  • Ruíz-Meana, Marisol
  • Girón, Cristina
  • Barba, Ignasi|||0000-0001-9886-3776
  • García Arumí, Elena|||0000-0003-1848-005X
  • García-Dorado, David|||0000-0002-1126-1279
  • Vázquez, Jesús|||0000-0003-1461-5092
  • Martí, Ramon A.|||0000-0002-8273-9540
  • Llovera, Marta
  • Sanchis, Daniel
The endonuclease G gene (Endog), which codes for a mitochondrial nuclease, was identified as a determinant of cardiac hypertrophy. How ENDOG controls cardiomyocyte growth is still unknown. Thus, we aimed at finding the link between ENDOG activity and cardiomyocyte growth. Endog deficiency induced reactive oxygen species (ROS) accumulation and abnormal growth in neonatal rodent cardiomyocytes, altering the AKT-GSK3β and Class-II histone deacethylases (HDAC) signal transduction pathways. These effects were blocked by ROS scavengers. Lack of ENDOG reduced mitochondrial DNA (mtDNA) replication independently of ROS accumulation. Because mtDNA encodes several subunits of the mitochondrial electron transport chain, whose activity is an important source of cellular ROS, we investigated whether Endog deficiency compromised the expression and activity of the respiratory chain complexes but found no changes in these parameters nor in ATP content. MtDNA also codes for humanin, a micropeptide with possible metabolic functions. Nanomolar concentrations of synthetic humanin restored normal ROS levels and cell size in Endog -deficient cardiomyocytes. These results support the involvement of redox signaling in the control of cardiomyocyte growth by ENDOG and suggest a pathway relating mtDNA content to the regulation of cell growth probably involving humanin, which prevents reactive oxygen radicals accumulation and hypertrophy induced by Endog deficiency.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Summation and Cancellation Effects on QRS and ST-Segment Changes Induced by Simultaneous Regional Myocardial Ischemia

  • Vives-Borrás, Miquel|||0000-0002-5345-4124
  • Jorge, Esther|||0000-0002-2777-0000
  • Amorós Figueras, Gerard|||0000-0002-2109-5550
  • Millán, Xavier|||0000-0001-6519-4190
  • Arzamendi, Dabit|||0000-0001-7543-5867
  • Cinca, Juan|||0000-0003-4819-4265
Simultaneous ischemia in two myocardial regions is a potentially lethal clinical condition often unrecognized whose corresponding electrocardiographic (ECG) patterns have not yet been characterized. Thus, this study aimed to determine the QRS complex and ST-segment changes induced by concurrent ischemia in different myocardial regions elicited by combined double occlusion of the three main coronary arteries. For this purpose, 12 swine were randomized to combination of 5-min single and double coronary artery occlusion: Group 1: left Circumflex (LCX) and right (RCA) coronary arteries (n = 4); Group 2: left anterior descending artery (LAD) and LCX (n = 4) and; Group 3: LAD and RCA (n = 4). QRS duration and ST-segment displacement were measured in 15-lead ECG. As compared with single occlusion, double LCX+RCA blockade induced significant QRS widening of about 40 ms in nearly all ECG leads and magnification of the ST-segment depression in leads V1-V3 (maximal 228% in lead V3, p < 0.05). In contrast, LAD+LCX or LAD+RCA did not induce significant QRS widening and markedly attenuated the ST-segment elevation in precordial leads (maximal attenuation of 60% in lead V3 in LAD+LCX and 86% in lead V5 in LAD+RCA, p < 0.05). ST-segment elevation in leads V7-V9 was a specific sign of single LCX occlusion. In conclusion, concurrent infero-lateral ischemia was associated with a marked summation effect of the ECG changes previously elicited by each single ischemic region. By contrast, a cancellation effect on ST-segment changes with no QRS widening was observed when the left anterior descending artery was involved.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Cell-Enriched Engineered Myocardial Graft Limits Infarct Size and Improves Cardiac Function

  • Perea Gil, Isaac
  • Prat-Vidal, Cristina|||0000-0002-5621-1101
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
  • Rudilla, F..
  • Llucià-Valldeperas, Aida
  • Soler-Botija, Carolina|||0000-0002-4584-9134
  • Iborra Egea, Oriol|||0000-0002-7280-859X
  • Díaz-Güemes, Idoia
  • Crisóstomo, Verónica|||0000-0003-1740-7029
  • Sánchez Margallo, Francisco Miguel|||0000-0003-2138-988X
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
Myocardial infarction (MI) remains a dreadful disease around the world, causing irreversible sequelae that shorten life expectancy and reduce quality of life despite current treatment. Here, the authors engineered a cell-enriched myocardial graft, composed of a decellularized myocardial matrix refilled with adipose tissue-derived progenitor cells (EMG-ATDPC). Once applied over the infarcted area in the swine MI model, the EMG-ATDPC improved cardiac function, reduced infarct size, attenuated fibrosis progression, and promoted neovascularization of the ischemic myocardium. The beneficial effects exerted by the EMG-ATDPC and the absence of identified adverse side effects should facilitate its clinical translation as a novel MI therapy in humans.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Potential role for clinical calibration to increase engagement with and application of home telemonitoring: a report from the HeartCycle programme

  • Gastelurrutia, Paloma|||0000-0001-6974-9210
  • Lupón, Josep|||0000-0002-5601-9611
  • Domingo, Mar|||0000-0002-2935-1272
  • Stut, Wim
  • Dovancescu, Silviu
  • Cleland, John
  • Frankenstein, Lutz
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
Aims: There is a need for alternative strategies that might avoid recurrent admissions in patients with heart failure. home telemonitoring (HTM) to monitor patient's symptoms from a distance may be useful. This study attempts to assess changes in HTM vital signs in response to daily life activities (variations in medication, salt intake, exercise, and stress) and to establish which variations affect weight, blood pressure, and heart rate. Methods and results: We assessed 76 patients with heart failure (mean age 76 ± 10.8 years, 75% male, mainly in NYHA class II/III and from ischaemic aetiology cause). Patients were given a calendar of interventions scheduling activities approximately twice a week before measuring their vital signs. Eating salty food or a large meal were the activities that had a significant impact on weight gain (+0.3 kg; P<0.001 and P = 0.006, respectively). Exercise and skipping a dose of medication other than diuretics increased heart rate (+3 bpm, P = 0.001 and almost +2 bpm, P = 0.016, respectively). Conclusions: Our HTM system was able to detect small changes in vital signs related to these activities. Further studies should assess if providing such a schedule of activities might be useful for patient education and could improve long-term adherence to recommended lifestyle changes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

GRECOS project (Genotyping Recurrence Risk of Stroke). The use of genetics to predict the vascular recurrence after stroke

  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Mendioroz, Maite|||0000-0002-4179-5781
  • Giralt, Dolors
  • Nafría, Cristina
  • Garcia, Elena
  • Carrera, Caty|||0000-0002-0804-0969
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Domingues-Montanari, Sophie
  • Delgado Martínez, María Pilar|||0000-0002-1628-4488
  • Ribo, Marc|||0000-0001-9242-043X
  • Castellanos, María del Mar|||0000-0003-3116-1352
  • Martínez, Sergi
  • Freijo, Mari Mar
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Rubiera, Marta
  • Álvarez Sabín, José|||0000-0002-8054-9209
  • Molina, Carlos A.|||0000-0001-6058-6259
  • Font, Maria Angels
  • Grau Olivares, Marta
  • Palomeras, Ernest|||0000-0002-0724-8653
  • Pérez de la Ossa, Natalia|||0000-0002-6063-211X
  • Martinez Zabaleta, Maite
  • Masjuan, Jaime|||0000-0003-1329-0943
  • Moniche, Francisco|||0000-0001-8613-2909
  • Cánovas Verge, David|||0000-0002-3483-8106
  • Piñana, Carlos|||0000-0001-7316-6202
  • Purroy, Francisco|||0000-0002-1808-5968
  • Cocho, Dolores
  • Navas, Inmaculada
  • Tejero, Carlos
  • Aymerich, Nuria
  • Cullell, Natalia|||0000-0001-5118-1014
  • Muiño, Elena|||0000-0001-5839-7328
  • Serena, Joaquín|||0000-0002-4478-7744
  • Rubio, Francisco
  • Dávalos, Antoni|||0000-0003-2949-5679
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Arenillas, Juan F.|||0000-0001-7464-6101
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Keene, Keith
  • Chen, Wei-Min
  • Worrall, Bradford
  • Sale, Michele
  • Arboix, Adrià|||0000-0002-8512-7881
  • Krupinski, Jerzy|||0000-0002-5136-8898
  • Montaner, Joan|||0000-0003-4845-2279
Background and Purpose-Vascular recurrence occurs in 11% of patients during the first year after ischemic stroke (IS) or transient ischemic attack (TIA). Clinical scores do not predict the whole vascular recurrence risk, therefore we aimed to find genetic variants associated with recurrence that might improve the clinical predictive mode is in IS. Methods-We analyzed 256 polymorphisms from 115 candidate genes in three patient cohorts comprising 4,482 IS or TIA patients. The discovery cohort was prospectively recruited and included 1,494 patients, 6.2% of them developed a new IS during the first year of follow-up. Replication analysis was performed in 2,988 patients using SNPlex or HumanOmni1-Quad technology. We generated a predictive model using Cox regression (GRECOS score), and generated risk groups using a classification tree method. Results-The analyses revealed that rs1800801 in the MGP gene (HR: 1.33, p= 9×10-03), a gene related to artery calcification, was associated with new IS during the first year of follow-up. This polymorphism was replicated in a Spanish cohort (n=1.305), however it was not significantly associated in a North American cohort (n=1.683). The GRECOS score predicted new IS (p=3.2×10-09) and could classify patients, from low risk of stroke recurrence (1.9%) to high risk (12.6%). Moreover, the addition of genetic risk factors to the GRECOS score improves the prediction compared to previous SPI-II score (p=0.03). Conclusions-The use of genetics could be useful to estimate vascular recurrence risk after IS. Genetic variability in the MGP gene was associated with vascular recurrence in the Spanish population.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer

  • Cedó, Lídia|||0000-0003-4354-3411
  • Garcia León, Annabel|||0000-0003-3007-9306
  • Baila-Rueda, Lucía
  • Santos, David|||0000-0003-1157-4969
  • Grijalva, Victor
  • Martínez Cignoni, Melanie Raquel|||0000-0002-3469-7980
  • Carbó, José María|||0000-0001-8301-5360
  • Metso, Jari
  • López Vilaró, Laura|||0000-0002-5428-8017
  • Zorzano Olarte, Antonio|||0000-0002-1638-0306
  • Valledor, Annabel F.|||0000-0003-4232-2633
  • Cenarro, Ana
  • Jauhiainen, Matti|||0000-0002-3836-3785
  • Lerma Puertas, Enrique|||0000-0001-7908-2747
  • Fogelman, Alan M.
  • Reddy, Srinivasa T.
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
Low levels of high-density lipoprotein cholesterol (HDLc) have been associated with breast cancer risk, but several epidemiologic studies have reported contradictory results with regard to the relationship between apolipoprotein (apo) A-I and breast cancer. We aimed to determine the effects of human apoA-I overexpression and administration of specific apoA-I mimetic peptide (D-4F) on tumour progression by using mammary tumour virus-polyoma middle T-antigen transgenic (PyMT) mice as a model of inherited breast cancer. Expression of human apoA-I in the mice did not affect tumour onset and growth in PyMT transgenic mice, despite an increase in the HDLc level. In contrast, D-4F treatment significantly increased tumour latency and inhibited the development of tumours. The effects of D-4F on tumour development were independent of 27-hydroxycholesterol. However, D-4F treatment reduced the plasma oxidized low-density lipoprotein (oxLDL) levels in mice and prevented oxLDL-mediated proliferative response in human breast adenocarcinoma MCF-7 cells. In conclusion, our study shows that D-4F, but not apoA-I-containing HDL, hinders tumour growth in mice with inherited breast cancer in association with a higher protection against LDL oxidative modification.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Detrimental effects of testosterone addition to estrogen therapy involve cytochrome P-450-induced 20-HETE synthesis in aorta of ovariectomized spontaneously hypertensive rat (SHR), a model of postmenopausal hypertension

  • Costa, Tiago J.
  • Ceravolo, G. S.
  • Echem, Cinthya
  • Hashimoto, C. M.
  • Costa, B. P.
  • Santos-Eichler, R. A.
  • Oliveira, M. A.
  • Jiménez Altayó, Francesc|||0000-0002-9034-2041
  • Akamine, Eliana Hiromi
  • Dantas, A. P.|||0000-0001-8514-4094
  • Carvalho, M. H. C.
Postmenopausal period has been associated to different symptoms such as hot flashes, vulvovaginal atrophy, hypoactive sexual desire disorder (HSDD) and others. Clinical studies have described postmenopausal women presenting HSDD can benefit from the association of testosterone to conventional hormonal therapy. Testosterone has been linked to development of cardiovascular diseases including hypertension and it also increases cytochrome P-450-induced 20-HETE synthesis which in turn results in vascular dysfunction. However, the effect of testosterone plus estrogen in the cardiovascular system is still very poorly studied. The aim of the present study is to evaluate the role of cytochrome P-450 pathway in a postmenopausal hypertensive female treated with testosterone plus estrogen. For that, hypertensive ovariectomized rats (OVX-SHR) were used as a model of postmenopausal hypertension and four groups were created: SHAM-operated (SHAM), ovariectomized SHR (OVX), OVX treated for 15 days with conjugated equine estrogens [(CEE) 9.6 μg/Kg/day/po] or CEE associated to testosterone [(CEE+T) 2.85 mg/kg/weekly/im]. Phenylephrine-induced contraction and generation of reactive oxygen species (ROS) were markedly increased in aortic rings from OVX-SHR compared to SHAM rats which were restored by CEE treatment. On the other hand, CEE+T abolished vascular effects by CEE and augmented both systolic and diastolic blood pressure of SHR. Treatment of aortic rings with the CYP/20-HETE synthesis inhibitor HET0016 (1 μM) reduced phenylephrine hyperreactivity and the augmented ROS generation in the CEE+T group. These results are paralleled by the increased CYP4F3 protein expression and activity in aortas of CEE+T. In conclusion, we showed that association of testosterone to estrogen therapy produces detrimental effects in cardiovascular system of ovariectomized hypertensive females via CYP4F3/20-HETE pathway. Therefore, our findings support the standpoint that the CYP/20-HETE pathway is an important therapeutic target for the prevention of cardiovascular disease in menopausal women in the presence of high levels of testosterone.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion

  • Penela, Petronila
  • Inserte, Javier|||0000-0003-2283-3591
  • Ramos, Paula
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • García-Dorado, David|||0000-0002-1126-1279
  • Mayor, F.
Background: Identification of signaling pathways altered at early stages after cardiac ischemia/reperfusion (I/R) is crucial to develop timely therapies aimed at reducing I/R injury. The expression of G protein-coupled receptor kinase 2 (GRK2), a key signaling hub, is up-regulated in the long-term in patients and in experimental models of heart failure. However, whether GRK2 levels change at early time points following myocardial I/R and its functional impact during this period remain to be established. Methods: We have investigated the temporal changes of GRK2 expression and their potential relationships with the cardioprotective AKT pathway in isolated rat hearts and porcine preclinical models of I/R. Findings: Contrary to the maladaptive up-regulation of GRK2 reported at later times after myocardial infarction, successive GRK2 phosphorylation at specific sites during ischemia and early reperfusion elicits GRK2 degradation by the proteasome and calpains, respectively, thus keeping GRK2 levels low during early I/R in rat hearts. Concurrently, I/R promotes decay of the prolyl-isomerase Pin1, a positive regulator of AKT stability, and a marked loss of total AKT protein, resulting in an overall decreased activity of this pro-survival pathway. A similar pattern of concomitant down-modulation of GRK2/AKT/Pin1 protein levels in early I/R was observed in pig hearts. Calpain and proteasome inhibition prevents GRK2/Pin1/AKT degradation, restores bulk AKT pathway activity and attenuates myocardial I/R injury in isolated rat hearts. Interpretation: Preventing transient degradation of GRK2 and AKT during early I/R might improve the potential of endogenous cardioprotection mechanisms and of conditioning strategies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Influence of ABO locus on PFA-100 collagen-ADP closure time is not totally dependent on the von willebrand factor. Results of a GWAS on gait-2 project phenotypes

  • Pujol-Moix, N.
  • Martinez-Perez, Angel|||0000-0002-5934-1454
  • Sabater-Lleal, Maria|||0000-0002-0128-379X
  • Llobet, D.
  • Vilalta, N.
  • Hamsten, Anders|||0000-0002-0618-0538
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
(1) Background: In a previous study, we found that two phenotypes related to platelet reactivity, measured with the PFA-100 system, were highly heritable. The aim of the present study was to identify genetic determinants that influence the variability of these phenotypes: Closure time of collagen-ADP (Col-ADP) and of collagen-epinephrine (Col-Epi). (2) Methods: As part of the GAIT-2 (Genetic Analysis of Idiopathic Thrombophilia (2) Project, 935 individuals from 35 large Spanish families were studied. A genome-wide association study (GWAS) with ≈ 10 M single nucleotide polymorphisms (SNPs) was carried out with Col-ADP and Col-Epi phenotypes. (3) Results: The study yielded significant genetic signals that mapped to the ABO locus. After adjusting both phenotypes for the ABO genotype, these signals disappeared. After adjusting for von Willebrand factor (VWF) or for coagulation factor VIII (FVIII), the significant signals disappeared totally for Col-Epi phenotype but only partially for Col-ADP phenotype. (4) Conclusion: Our results suggest that the ABO locus exerts the main genetic influence on PFA-100 phenotypes. However, while the effect of the ABO locus on Col-Epi phenotype is mediated through VWF and/or FVIII, the effect of the ABO locus on Col-ADP phenotype is partly produced through VWF and/or FVIII, and partly through other mechanisms.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Electrocardiographic Distinction of Left Circumflexand Right Coronary Artery Occlusion in PatientsWith Inferior Acute Myocardial Infarction

  • Vives-Borrás, Miquel|||0000-0002-5345-4124
  • Maestro, Alba|||0000-0003-1785-3125
  • García-Hernando, Victor
  • Jorgensen, D.
  • Ferrero-Gregori, Andreu|||0000-0001-6492-2416
  • Moustafa, Abdel Hakim|||0000-0001-6077-6888
  • Solé González, Eduard|||0000-0002-5727-9925
  • Noriega, Francisco J.|||0000-0003-3198-8552
  • Alvarez-Garcia, Jesus|||0000-0002-2015-6446
  • Cinca, Juan|||0000-0003-4819-4265
Previously reported electrocardiographic (ECG) criteria to distinguish left circumflex (LCCA) and right coronary artery (RCA) occlusion in patients with acute inferior ST-segment elevation myocardial infarction (STEMI) afford a modest diagnostic accuracy. We aimed to develop a new algorithm overcoming limitations of previous studies. Clinical, ECG, and coronary angiographic data were analyzed in 230 nonselected patients with acute inferior STEMI who underwent primary percutaneous coronary intervention. A decision-tree analysis was used to develop a new ECG algorithm. The diagnostic accuracy of reported ECG criteria was reviewed. LCCA occlusion occurred in 111 cases and RCA in 119. We developed a 3-step algorithm that identified LCCA and RCA occlusion with a sensitivity of 77%, specificity of 86%, accuracy of 82%, and Youden index of 0.63. The area under the ROC curve was 0.85 and resulted 0.82 after a 10-fold cross validation. The key leads for LCCA occlusion were V3 (ST depression in V3/ST elevation in III.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Estudio descriptivo de los stroke mimics después de un estudio neurovascular completo, Description of stroke mimics after complete neurovascular assessment

  • Avellaneda-Gómez, Carla|||0000-0003-4851-1224
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Gomez Gonzalez, Alejandra|||0000-0001-7266-5253
  • Serra Martínez, Maria
  • de Ceballos Cerrajería, Pablo
  • Zabalza, Ana|||0000-0003-3860-5251
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Ois, Angel|||0000-0002-1375-5950
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Roquer González, Jaume|||0000-0001-5992-2606
Introducción: Un porcentaje de casos diagnosticados inicialmente como infartos isquémicos son de causa no cerebrovascular o stroke mimics (SM). Los datos publicados al respecto son heterogéneos y, generalmente, con cohortes pequeñas. Objetivo: Nuestro objetivo es establecer qué enfermedades cursan como SM, definir sus características epidemiológicas y clínicas e identificar el porcentaje de casos tratados con fibrinólisis. Métodos: Registro prospectivo de los eventos considerados cerebrovasculares desde junio del 2005 a abril del 2015, analizando datos demográficos, factores de riesgo cardiovascular, activación de Código Ictus e ingreso, severidad (NIHSS), destino al alta, morbilidad (mRS) y tratamiento recibido. Se han comparado los ictus isquémicos con los SM. Se excluyeron las hemorragias intracraneales, subaracnoideas y las causas de SM detectables en la TC inicial. Resultados: Sobre 4.570 casos, 404 (8,8%) son SM. Los pacientes con SM son más jóvenes (70,3 vs. 74 años, p < 0,0001), tienen menos factores de riesgo cardiovascular y fibrilación auricular (13 vs. 34%, p < 0,0001), una menor puntuación en NIHSS (2 vs. 4, p < 0,0001) y menos afasia (9,4 vs. 19,6%, p < 0,02) y disfagia (1,2 vs. 17%, p < 0,0001). En los SM se activan menos códigos ictus (28 vs. 40%, p < 0,0001) y requieren menos días de ingreso (4,9 vs. 7,8; p < 0,0001) y menos ingresos en la unidad de ictus (47 vs. 60%, p < 0,0001). Los SM son dados de alta a domicilio con mayor frecuencia (95 vs. 62%, p < 0,0001) y con menor discapacidad (mRS 0-2; 76 vs. 54%, p < 0,0001). Un 4,7% de los SM recibieron fibrinólisis. La primera causa de SM fueron las crisis epilépticas (26%). Conclusiones: Los SM supusieron el 8,8% de los ingresos con diagnóstico inicial de ictus isquémico. Los SM tienen características demográficas, clínicas y pronósticas diferentes, siendo la epilepsia la etiología más frecuente. Pese a recibir atención urgente especializada, 19 pacientes (4,7%) fueron trataron con fibrinólisis., Introduction: A considerable percentage of events initially diagnosed as ischaemic stroke have non-cerebrovascular causes; these are called stroke mimics (SM). Currently available evidence about these events is heterogeneous and comes from studies with small samples. Objective: The purpose of our study is to identify conditions that may present as SM, define their epidemiological and clinical characteristics, and determine the percentage of cases of SM treated with intravenous fibrinolysis. Methods: Prospective study including all patients admitted to a tertiary university hospital between June 2005 and April 2015 with a diagnosis of acute stroke. We analysed demographic data, cardiovascular risk factors, time from code stroke activation to admission, stroke severity (NIHSS), final destination after discharge, degree of disability (mRS), and treatment. We compared SM and ischaemic strokes. We ruled out patients with intracranial haemorrhage, subarachnoid haemorrhage, or other causes of SM that may be detected on the baseline CT scan. Results: Four hundred four of the 4,570 included patients (8.8%) were found to have SM. Patients with SM were younger (70.3 vs. 74, P <.0001), less likely to exhibit cardiovascular risk factors and atrial fibrillation (13 vs. 34%, P <.0001), scored lower on the NIHSS at baseline (2 vs. 4, P <.0001), and included fewer cases of aphasia (9.4 vs. 19.6%, P <.02) and dysphagia (1.2 vs. 17%, P <.0001) than patients with stroke. SM caused fewer code stroke activations (28 vs. 40%, P <.0001). Patients with SM required shorter hospital stays (4.9 vs. 7.8 days, P <.0001), were less frequently admitted to the stroke unit (47 vs. 60%, P <.0001) and more frequently discharged home (95 vs. 62%, P <.0001), and had better outcomes (mRS scores 0-2; 76 vs. 54%, P <.0001). Intravenous fibrinolysis was administered to 4.7% of these patients. Epileptic seizures were the most frequent cause of SM (26%). Conclusions: In our sample, 8.8% of all diagnoses of ischaemic stroke were SM. These events have different demographic, clinical, and prognostic characteristics; epilepsy is the most common aetiology. Despite receiving specialised emergency care, 19 patients with SM (4.7%) were treated with intravenous fibrinolysis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sex differences in the 1 H NMR metabolic profile of serum in cardiovascular risk patients

  • Barba, Ignasi|||0000-0001-9886-3776
  • Andrés Villareal, Mireia|||0000-0002-0657-5855
  • Picón, Irene
  • Aguadé-Bruix, Santiago|||0000-0001-8617-6274
  • García-Dorado, David|||0000-0002-1126-1279
Personalized diagnosis and risk stratification of cardiovascular diseases would allow optimizing therapeutic strategies and lifestyle changes. Metabolomics is a promising technique for personalized diagnosis and prognosis; however, various physiological parameters, including sex, influence the metabolic profile thus hampering its translation to the clinic. Knowledge of the variation in the metabolic profile associated with sex would facilitate metabolomic translation to the clinic. The objective of the present work was to investigate the possible differences in the metabolic H NMR profile associated to sex beyond lipoproteins. H NMR spectra from whole serum and methanol deproteinized samples from 39 patients (22 males, 17 females) between 55-70 years old with suspected coronary artery disease that underwent a stress test that was considered negative where included. Deproteinized serum could be used to differentiate sex based on higher levels of lactate and glucose in women. Lipoprotein region was the most variable area of the spectra between individuals, but spectra of whole serum were able to differentiate sex based on lipoproteins. There are sex-related differences in the H NMR metabolic profile of individuals with suspected cardiovascular disease beyond lipoproteins. These findings may help the translation of metabolomics to the clinic.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long-Term Stroke Recurrence after Transient Ischemic Attack, Implications of Etiology

  • Ois, Angel|||0000-0002-1375-5950
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Soriano-Tarraga, Carolina
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Avellaneda-Gómez, Carla|||0000-0003-4851-1224
  • Cascales, Diego
  • Fernandez-Perez, Isabel|||0000-0002-9949-1393
  • Roquer González, Jaume|||0000-0001-5992-2606
To analyze long-term stroke recurrence (SR) characteristics after transient ischemic attack (TIA) according to initial etiological classification. A prospective cohort of 706 TIA patients was followed up in a single tertiary stroke center. Endpoint was SR. Etiologic subgroup was determined according to the evidence-based causative classification system. Location of TIA and SR was recorded as right, left, or posterior territory. Disability stroke recurrence (DSR) was defined as modified Rankin Scale (mRS) score.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Combined study of 13 and complement genes in the diagnosis of thrombotic microangiopathies using next-generation sequencing

  • Fidalgo, Teresa|||0000-0003-4495-4431
  • Martinho, Patrícia
  • Pinto, Catarina S.
  • Oliveira, Ana C.|||0000-0003-1427-8831
  • Salvado, Ramon
  • Borràs, Nina
  • Coucelo, Margarida
  • Manco, Licínio
  • Maia, Tabita
  • Mendes, M. João
  • Del Orbe Barreto, Rafael Andrés|||0000-0002-1240-1958
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Vidal, Francisco|||0000-0001-8089-4945
  • Ribeiro, M. Letícia
The 2 main forms of thrombotic microangiopathy () are thrombotic thrombocytopenic purpura () and atypical hemolytic uremic syndrome (). Deficiency of 13 and dysregulation of the complement pathway result in and , respectively; however, overlap of their clinical characteristics makes differential diagnosis challenging. We aimed to develop a diagnosis workflow based on 13 activity and screening of ADAMTS13 and complement genes using a custom next-generation sequencing () gene panel. For this, from a cohort of 154 Portuguese patients with acute , the genotype-phenotype correlations were analyzed in 7 hereditary (13 activity <10%, no inhibitor), 36 acquired (13 activity <10%, presence of an inhibitor), and in 34 presumable . In total, 37 different rare variants, 8 of which novel (in ADAMTS13, , and CD46), were identified across 7 genes. Thirteen patients were homozygous (n=6), compound heterozygous (n=2), and heterozygous (n=5) for 11 ADAMTS13 variants (6 pathogenic mutations). Among the 34 patients, 17 were heterozygous for 23 variants in the different complement genes with distinct consequences, ranging from single pathogenic mutations associated with complete disease penetrance to benign variants that cause only when combined with other variants and/or and CD46 risk haplotypes or CFHR1-3 deletion. Our study provides evidence of the usefulness of the panel as an excellent technology that enables more rapid diagnosis of , and is a valuable asset in clinical practice to discriminate between and .
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Unraveling the effect of silent, intronic and missense mutations on VWF splicing, contribution of next generation sequencing in the study of mRNA

  • Borràs, Nina
  • Orriols, Gerard|||0000-0002-1138-5909
  • Batlle, Javier|||0000-0002-7931-2546
  • Pérez-Rodríguez, Almudena
  • Fidalgo, Teresa|||0000-0003-4495-4431
  • Martinho, Patrícia
  • López-Fernández, María Fernanda
  • Rodríguez-Trillo, Ángela
  • Lourés, Esther
  • Parra, Rafael
  • Altisent, Carmen
  • Cid, Ana Rosa
  • Bonanad, Santiago|||0000-0002-8390-8211
  • Cabrera, Noelia
  • Moret, Andrés
  • Mingot-Castellano, María Eva|||0000-0001-9083-855X
  • Navarro, Nira
  • Pérez-Montes, Rocío
  • Marcellin, Sally
  • Moreto, Ana
  • Herrero, Sonia
  • Soto, Inmaculada
  • Fernández Mosteirín, Núria
  • Jiménez-Yuste, Víctor|||0000-0003-3937-3499
  • Alonso, Nieves
  • de Andrés Jacob, Aurora
  • Fontanes, Emilia
  • Campos, Rosa
  • Paloma, María José
  • Bermejo, Nuria
  • Berrueco, Rubén|||0000-0002-1068-7489
  • Mateo, Jose|||0000-0002-4227-3256
  • Arribalzaga, Karmele
  • Marco, Pascual
  • Palomo Bravo, Ángeles
  • Quismondo, Nerea Castro
  • Iñigo, Belén
  • Nieto Hernández, Maria del Mar
  • Vidal, Rosa
  • Martínez, María Paz
  • Aguinaco, Reyes
  • Tenorio, Jesús María
  • Ferreiro, María
  • García-Frade, Javier
  • Rodríguez-Huerta, Ana María
  • Cuesta, Jorge
  • Rodríguez-González, Ramón
  • García-Candel, Faustino|||0000-0002-6369-6004
  • Dobón, Manuela
  • Aguilar Franco, Carlos
  • Vidal, Francisco|||0000-0001-8089-4945
  • Corrales Insa, Irene|||0000-0002-0647-0340
Large studies in von Willebrand disease patients, including Spanish and Portuguese registries, led to the identification of.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction

  • Fernández-Bergés, Daniel|||0000-0002-9561-2901
  • Degano, Irene R.|||0000-0003-1914-6934
  • Gonzalez Fernandez, Reyes
  • Subirana, Isaac|||0000-0003-1676-0197
  • Vila, Joan
  • Jiménez-Navarro, Manuel|||0000-0002-6759-0514
  • Pérez-Fernández, Silvia|||0000-0002-9756-0092
  • Roqué, Mercè
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Fernández Avilés, Francisco|||0000-0001-5501-5275
  • Mayorga, Antonio
  • Bertomeu-González, Vicente|||0000-0001-5309-0562
  • Sanchis, Juan|||0000-0003-0797-8709
  • Rodríguez Esteban, Marcos
  • Sánchez Hidaldo, Antonio|||0000-0003-0710-3160
  • Sanchez-Insa, Esther
  • Elorriaga, Ane
  • Abu-Assi, Emad|||0000-0003-1568-3118
  • Nuñez, Alberto
  • Garcia Ruiz, Jose Manuel
  • Morrondo Valdeolmillos, Pedro
  • Bosch-Portell, Daniel
  • Lekuona, Iñaki
  • Carrillo-Lopez, Andres
  • Zamora, Alberto|||0000-0001-6907-0654
  • Vega-Hernandez, Berta
  • Alameda Serrano, Javier
  • Rubert, Catalina
  • Ruiz-Valdepeñas, Luis
  • Quintas, Laura
  • Rodríguez-Padial, Luis|||0000-0002-5783-3922
  • Vaquero, Jessica
  • Martinez Dolz, Luis
  • Barrabés, José A.|||0000-0001-7062-6277
  • Sánchez Fernández, Pedro Luis|||0000-0002-1402-0526
  • Sionis, Alessandro|||0000-0003-0843-9512
  • Martí Almor, Julio|||0000-0001-9927-1190
  • Elosua, Roberto|||0000-0001-8235-0095
  • Lidón, Rosa María|||0000-0001-7008-2716
  • García-Dorado, David|||0000-0002-1126-1279
  • Marrugat, Jaume|||0000-0003-3320-554X
Primary percutaneous coronary intervention (P-PCI) has demonstrated its efficacy in patients with ST segment elevation myocardial infarction (STEMI). However, patients with STEMI ≥75 years receive less P-PCI than younger patients despite their higher in-hospital morbimortality. The objective of this analysis was to determine the effectiveness of P-PCI in patients with STEMI ≥75 years. We included 979 patients with STEMI ≥75 years, from the ATención HOspitalaria del Síndrome coronario study, a registry of 8142 consecutive patients with acute coronary syndrome admitted at 31 Spanish hospitals in 2014-2016. We calculated a propensity score (PS) for the indication of P-PCI. Patients that received or not P-PCI were matched by PS. Using logistic regression, we compared the effectiveness of performing P-PCI versus non-performance for the composite primary event, which included death, reinfarction, acute pulmonary oedema or cardiogenic shock during hospitalisation. Of the included patients, 81.5 % received P-PCI. The matching provided two groups of 169 patients with and without P-PCI. Compared with its non-performance, P-PCI presented a composite event OR adjusted by PS of 0.55 (95% CI 0.34 to 0.89). Receiving a P-PCI was significantly associated with a reduced risk of major intrahospital complications in patients with STEMI aged 75 years or older.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Simple Score to Identify Super-Responders to Sacubitril/Valsartan in Ambulatory Patients With Heart Failure

  • Moliner-Abós, Carles|||0000-0002-9264-5804
  • Mojón Álvarez, Diana
  • Rivas-Lasarte, Mercedes|||0000-0002-8704-3104
  • Belarte Tornero, Laia Carla|||0000-0003-2774-1290
  • Pamies Besora, Julia
  • Solé González, Eduard|||0000-0002-5727-9925
  • Fluvià, Paula|||0000-0002-4683-9122
  • Zegrí-Reiriz, Isabel|||0000-0001-9742-8537
  • López López, Laura|||0000-0002-8653-6206
  • Brossa Loidi, Vicens|||0000-0003-0403-6425
  • Pirla, Maria José
  • Mesado, Nuria
  • Mirabet Pérez, Sonia|||0000-0001-5955-2748
  • Roig, Eulàlia|||0000-0002-3421-4985
  • Alvarez-Garcia, Jesus|||0000-0002-2015-6446
Sacubitril/valsartan (SV) promotes cardiac remodeling and improves prognosis in patients with heart failure (HF). However, the response to the drug may vary between patients and its implementation in daily clinical practice has been slower than expected. Our objective was to develop a score predicting the super-response to SV in HF outpatients. This is a retrospective analysis of 185 consecutive patients prescribed SV from two tertiary hospitals between September 2016 and February 2018. Super-responder was defined as a patient taking the drug and (i) without HF admissions, death, or heart transplant, and (ii) with a ≥50% reduction in NT-proBNP levels and/or an increase of ≥10 points in LVEF in a 12-month follow-up period after starting SV. Clinical, echocardiographic, ECG, and biochemical variables were used in a logistic regression analysis to construct a score for super-response to SV which was internally validated using bootstrap method. Out of 185 patients, 65 (35%) fulfilled the super-responder criteria. Predictors for super-response to SV were absence of both previous aldosterone antagonist and diuretic treatment, NYHA I-II class, female gender, previous 1-year HF admission, and sinus rhythm. An integrating score distinguished a low- (<25%), intermediate- (∼46%), and high-probability (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Detailed phenotyping of posterior vs. anterior circulation ischemic stroke, a multi-center MRI study

  • Frid, Petrea|||0000-0003-1452-2064
  • Drake, Mattias
  • Giese, Anne-Katrin
  • Wasselius, Johan|||0000-0003-1896-381X
  • Schirmer, Markus D.
  • Donahue, Kathleen L.
  • Cloonan, Lisa
  • Irie, Robert E.
  • Bouts, Mark|||0000-0003-2297-7499
  • McIntosh, Elissa C.
  • Mocking, Steven J. T.
  • Dalca, Adrian Vasile|||0000-0002-8422-0136
  • Sridharan, Ramesh
  • Xu, Huichun|||0000-0001-8118-9607
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Holmegaard, Lukas
  • Jood, Katarina|||0000-0001-8746-1771
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Cole, John W.|||0000-0001-9263-8930
  • McArdle, Patrick F.
  • Broderick, Joseph P.|||0000-0002-7323-7709
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Jern, Christina
  • Kissela, Brett|||0000-0002-9773-4013
  • Kleindorfer, Dawn O.
  • Lemmens, Robin C.
  • Meschia, James Frederick
  • Rundek, Tatjana R.
  • Sacco, Ralph L.
  • Schmidt, Reinhold
  • Sharma, Pankaj K.
  • Slowik, Agnieszka Julia
  • Thijs, Vincent|||0000-0002-6614-8417
  • Woo, Daniel
  • Worrall, Bradford B.|||0000-0001-9386-4091
  • Kittner, Steven J.
  • Mitchell, Braxton|||0000-0003-4920-4744
  • Petersson, Jesper
  • M., Jonathan
  • Golland, Polina
  • Wu, Ona
  • Rost, Natalia Sana
  • Lindgren, Arne G.|||0000-0003-1942-7330
Posterior circulation ischemic stroke (PCiS) constitutes 20-30% of ischemic stroke cases. Detailed information about differences between PCiS and anterior circulation ischemic stroke (ACiS) remains scarce. Such information might guide clinical decision making and prevention strategies. We studied risk factors and ischemic stroke subtypes in PCiS vs. ACiS and lesion location on magnetic resonance imaging (MRI) in PCiS. Out of 3,301 MRIs from 12 sites in the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Genetics Network (SiGN), we included 2,381 cases with acute DWI lesions. The definition of ACiS or PCiS was based on lesion location. We compared the groups using Chi-squared and logistic regression. PCiS occurred in 718 (30%) patients and ACiS in 1663 (70%). Diabetes and male sex were more common in PCiS vs. ACiS (diabetes 27% vs. 23%, p < 0.05 ; male sex 68% vs. 58%, p < 0.001). Both were independently associated with PCiS (diabetes, OR = 1.29; 95% CI 1.04-1.61; male sex, OR = 1.46; 95% CI 1.21-1.78). ACiS more commonly had large artery atherosclerosis (25% vs. 20%, p < 0.01) and cardioembolic mechanisms (17% vs. 11%, p < 0.001) compared to PCiS. Small artery occlusion was more common in PCiS vs. ACiS (20% vs. 14%, p < 0.001). Small artery occlusion accounted for 47% of solitary brainstem infarctions. Ischemic stroke subtypes differ between the two phenotypes. Diabetes and male sex have a stronger association with PCiS than ACiS. Definitive MRI-based PCiS diagnosis aids etiological investigation and contributes additional insights into specific risk factors and mechanisms of injury in PCiS. The online version of this article (10.1007/s00415-019-09613-5) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size

  • Valls-Lacalle, Laura|||0000-0002-7185-0454
  • Barba, Ignasi|||0000-0001-9886-3776
  • Miró-Casas, Elisabet|||0000-0002-2058-5961
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • García-Dorado, David|||0000-0002-1126-1279
Inhibition of succinate dehydrogenase (SDH) with malonate during reperfusion reduces infarct size in isolated mice hearts submitted to global ischemia. However, malonate has toxic effects that preclude its systemic administration in animals. Here we investigated the effect of intracoronary malonate on infarct size in pigs submitted to transient coronary occlusion. Under baseline conditions, 50 mmol/L of intracoronary disodium malonate, but not lower concentrations, transiently reduced systolic segment shortening in the region perfused by the left anterior descending coronary artery (LAD) in open-chest pigs. To assess the effects of SDH inhibition on reperfusion injury, saline or malonate 10 mmol/L were selectively infused into the area at risk in 38 animals submitted to ischemia-reperfusion. Malonate improved systolic shortening in the area at risk two hours after 15 min of ischemia (0.18 ± 0.07 vs 0.00 ± 0.01 a.u., p = 0.025, n = 3). In animals submitted to 40 min of ischemia, malonate reduced reactive oxygen species production (MitoSOX staining) during initial reperfusion and limited infarct size (36.46 ± 5.35 vs 59.62 ± 4.00%, p = 0.002, n = 11), without modifying reperfusion arrhythmias. In conclusion, inhibition of SDH with intracoronary malonate during early reperfusion limits reperfusion injury and infarct size in pigs submitted to transient coronary occlusion without modifying reperfusion arrhythmias or contractile function in distant myocardium.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis, Lessons from the PCM-EVW-ES Spanish project

  • Pérez-Rodríguez, Almudena
  • Batlle, Javier|||0000-0002-7931-2546
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Borràs, Nina
  • Rodríguez-Trillo, Ángela
  • Lourés, Esther
  • Cid, Ana Rosa
  • Bonanad, Santiago|||0000-0002-8390-8211
  • Cabrera, Noelia
  • Moret, Andrés
  • Parra, Rafael
  • Mingot-Castellano, María Eva|||0000-0001-9083-855X
  • Navarro, Nira
  • Altisent, Carmen
  • Pérez-Montes, Rocío
  • Marcellini, Shally
  • Moreto, Ana
  • Herrero, Sonia
  • Soto, Inmaculada
  • Fernández Mosteirín, Núria
  • Jiménez-Yuste, Víctor|||0000-0003-3937-3499
  • Alonso, Nieves
  • de Andrés Jacob, Aurora
  • Fontanes, Emilia
  • Campos, Rosa
  • Paloma, María José
  • Bermejo, Nuria
  • Berrueco, Rubén|||0000-0002-1068-7489
  • Mateo, Jose|||0000-0002-4227-3256
  • Arribalzaga, Karmele
  • Marco, Pascual
  • Palomo Bravo, Ángeles
  • Castro Quismondo, Nerea
  • Iñigo, Belén
  • Nieto Hernández, Maria del Mar
  • Vidal, Rosa
  • Martínez, María Paz
  • Aguinaco, Reyes
  • Tenorio Núñez, María Concepción
  • Ferreiro, María
  • García-Frade, Javier
  • Rodríguez-Huerta, Ana María
  • Cuesta, Jorge
  • Rodríguez-González, Ramón
  • García-Candel, Faustino|||0000-0002-6369-6004
  • Dobón, Manuela
  • Aguilar Franco, Carlos
  • Batlle, Fernando
  • Vidal, Francisco|||0000-0001-8089-4945
  • López-Fernández, María Fernanda
The multimeric analysis (MA) of plasma von Willebrand factor (VWF) evaluates structural integrity and helps in the diagnosis of von Willebrand disease (VWD). This assay is a matter of controversy, being considered by some investigators cumbersome and only slightly informative. The centralised study 'Molecular and Clinical Profile of von Willebrand Disease in Spain (PCM-EVW-ES)' has been carried out by including the phenotypic assessment and the genetic analysis by next generation sequencing (NGS) of the VWF gene (VWF). The aim of the present study was to evaluate the role of MA to the diagnosis of these patients and their potential discrepancies. Two hundred and seventy out of 480 patients centrally diagnosed with VWD had normal multimers, 168 had abnormal multimers and 42 a total absence of multimers. VWF MA was of great significance in the diagnosis of 83 patients (17.3%), it was also of help in the diagnosis achieved in 365 additional patients (76%) and was not informative in 32 cases (6.7%). With regard to discrepancies, 110 out of 480 (23%) patients centrally diagnosed with VWD presented some kind of discordance between VWF:RCo/VWF:Ag and/or VWF:CB/VWF:Ag ratios, multimeric study and/or genetic results. The VWF MA was key in the presence of novel mutations as well as in cases with phenotypic discrepancies. A comparison between the contribution of MA and VWF:CB showed a clearly higher contribution of the former in the diagnostic process. These data seem to reinforce the relevance of the VWF MA in VWD diagnosis, despite all its limitations.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations, insights from an observational cohort study

  • González-Costello, José|||0000-0002-7437-3630
  • Comín-Colet, Josep|||0000-0001-8780-720X
  • Lupón, Josep|||0000-0002-5601-9611
  • Enjuanes, Cristina|||0000-0002-7916-1223
  • de Antonio Ferrer, Marta|||0000-0002-4319-797X
  • Fuentes, Lara
  • Moliner-Borja, Pedro
  • Farré, Núria|||0000-0003-3110-6572
  • Zamora, Elisabet|||0000-0001-5317-7481
  • Manito, Nicolás
  • Pujol Vallverdú, Ramón M.|||0000-0002-5622-6055
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
Iron deficiency (ID) in patients with chronic heart failure (CHF) is considered an adverse prognostic factor. We aimed to evaluate if ID in patients with CHF is associated with increased mortality and hospitalizations. We evaluated ID in patients with CHF at 3 university hospitals. ID was defined as absolute (ferritin < 100 μg/L) or functional (transferrin Saturation index < 20% and ferritin between 100 and 299 μg/L). We excluded patients who received treatment with intravenous Iron or Erythropoietin during follow-up. We evaluated if ID was a predictor of death or hospitalization due to heart failure or any cause using univariate and multivariate cox regression analysis. We included 1684 patients, 65% males, 38% diabetics, median age of 72 years, 37% in functional class III-IV and 30% of patients with a left ventricular ejection fraction.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Next generation sequencing to dissect the genetic architecture of KNG1 and F11 loci using factor XI levels as an intermediate phenotype of thrombosis

  • Martin-Fernandez, Laura|||0000-0002-8909-508X
  • Gavidia-Bovadilla, Giovana
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Brunel, Helena|||0000-0002-1036-7928
  • Ramírez, Lorena
  • López, Sonia|||0000-0002-5023-5153
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Vidal, Francisco|||0000-0001-8089-4945
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
Venous thromboembolism is a complex disease with a high heritability. There are significant associations among Factor XI (FXI) levels and SNPs in the KNG1 and F11 loci. Our aim was to identify the genetic variation of KNG1 and F11 that might account for the variability of FXI levels. The KNG1 and F11 loci were sequenced completely in 110 unrelated individuals from the GAIT-2 (Genetic Analysis of Idiopathic Thrombophilia 2) Project using Next Generation Sequencing on an Illumina MiSeq. The GAIT-2 Project is a study of 935 individuals in 35 extended Spanish families selected through a proband with idiopathic thrombophilia. Among the 110 individuals, a subset of 40 individuals was chosen as a discovery sample for identifying variants. A total of 762 genetic variants were detected. Several significant associations were established among common variants and low-frequency variants sets in KNG1 and F11 with FXI levels using the PLINK and SKAT packages. Among these associations, those of rs710446 and five low-frequency variant sets in KNG1 with FXI level variation were significant after multiple testing correction and permutation. Also, two putative pathogenic mutations related to high and low FXI levels were identified by data filtering and in silico predictions. This study of KNG1 and F11 loci should help to understand the connection between genotypic variation and variation in FXI levels. The functional genetic variants should be useful as markers of thromboembolic risk.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets, A Link between Inflammation, Atherosclerosis, and Thrombosis

  • Badimon, Lina|||0000-0002-9162-2459
  • Suades, Rosa|||0000-0002-0193-3115
  • Fuentes, Eduardo
  • Palomo, Iván
  • Padró, Teresa|||0000-0003-1921-954X
Reports in the last decade have suggested that the role of platelets in atherosclerosis and its thrombotic complications may be mediated, in part, by local secretion of platelet-derived microvesicles (pMVs), small cell blebs released during the platelet activation process. MVs are the most abundant cell-derived microvesicle subtype in the circulation. High concentrations of circulating MVs have been reported in patients with atherosclerosis, acute vascular syndromes, and/or diabetes mellitus, suggesting a potential correlation between the quantity of microvesicles and the clinical severity of the atherosclerotic disease. pMVs are considered to be biomarkers of disease but new information indicates that pMVs are also involved in signaling functions. pMVs evoke or promote haemostatic and inflammatory responses, neovascularization, cell survival, and apoptosis, processes involved in the pathophysiology of cardiovascular disease. This review is focused on the complex cross-talk between platelet-derived microvesicles, inflammatory cells and vascular elements and their relevance in the development of the atherosclerotic disease and its clinical outcomes, providing an updated state-of-the art of pMV involvement in atherothrombosis and pMV potential use as therapeutic agent influencing cardiovascular biomedicine in the future.
Dipòsit Digital de Documents de la UAB
Publicación Contribución de congreso (ConferenceOutput)

Ischaemic conditioning and targeting reperfusion injury, a 30 year voyage of discovery

  • Hausenloy, Derek J.
  • Barrabés, José A.|||0000-0001-7062-6277
  • Bøtker, Hans Erik|||0000-0001-6358-8962
  • Davidson, Sean M.|||0000-0001-5182-4980
  • Di Lisa, Fabio
  • Downey, James
  • Engstrom, Thomas
  • Ferdinandy, Péter|||0000-0002-6424-6806
  • Carbrera-Fuentes, Hector A.
  • Heusch, Gerd
  • Ibañez, Borja|||0000-0002-5036-254X
  • Iliodromitis, Efstathios K.
  • Inserte, Javier|||0000-0003-2283-3591
  • Jennings, Robert
  • Kalia, Neena
  • Kharbanda, Rajesh
  • Lecour, Sandrine|||0000-0003-1942-8974
  • Marber, Michael
  • Miura, Tetsuji|||0000-0001-5024-7085
  • Ovize, Michel
  • Perez-Pinzon, Miguel A.
  • Piper, Hans Michael
  • Przyklenk, Karin
  • Schmidt, Michael Rahbek
  • Redington, Andrew
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Vilahur, Gemma|||0000-0002-2828-8873
  • Vinten-Johansen, Jakob
  • Yellon, Derek|||0000-0001-7791-9320
  • García-Dorado, David|||0000-0002-1126-1279
To commemorate the auspicious occasion of the 30th anniversary of IPC, leading pioneers in the field of cardioprotection gathered in Barcelona in May 2016 to review and discuss the history of IPC, its evolution to IPost and RIC, myocardial reperfusion injury as a therapeutic target, and future targets and strategies for cardioprotection. This article provides an overview of the major topics discussed at this special meeting and underscores the huge importance and impact, the discovery of IPC has made in the field of cardiovascular research.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Unravelling of the Genetic Architecture of Plasminogen Deficiency and its Relation to Thrombotic Disease

  • Martin-Fernandez, Laura|||0000-0002-8909-508X
  • Marco, Pascual
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Pérez, Raquel
  • Ramírez, Lorena
  • López, Sonia|||0000-0002-5023-5153
  • Vidal, Francisco|||0000-0001-8089-4945
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
Although plasminogen is a key protein in fibrinolysis and several mutations in the plasminogen gene (PLG) have been identified that result in plasminogen deficiency, there are conflicting reports to associate it with the risk of thrombosis. Our aim was to unravel the genetic architecture of PLG in families with plasminogen deficiency and its relationship with spontaneous thrombotic events in these families. A total of 13 individuals from 4 families were recruited. Their genetic risk profile of thromboembolism was characterized using the Thrombo inCode kit. Only one family presented genetic risk of thromboembolism (homozygous carrier of F12 rs1801020 and F13A1 rs5985). The whole PLG was tested using Next Generation Sequencing (NGS) and 5 putative pathogenic mutations were found (after in silico predictions) and associated with plasminogen deficiency. Although we can not find genetic risk factors of thrombosis in 3 of 4 families, even the mutations associated with plasminogen deficiency do not cosegregated with thrombosis, we can not exclude plasminogen deficiency as a susceptibility risk factor for thrombosis, since thrombosis is a multifactorial and complex disease where unknown genetic risk factors, in addition to plasminogen deficiency, within these families may explain the thrombotic tendency.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Neoinnervation and neovascularization of acellular pericardial-derived scaffolds in myocardial infarcts

  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
  • Fernandez-Figueras, M. Teresa
  • Martí, Mercè|||0000-0002-1846-0043
  • Soler-Botija, Carolina|||0000-0002-4584-9134
  • Roura, Santiago|||0000-0003-4063-9661
  • Perea Gil, Isaac
  • Prat-Vidal, Cristina|||0000-0002-5621-1101
  • Llucià-Valldeperas, Aida
  • Raya, Ángel|||0000-0003-2189-9775
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
Engineered bioimplants for cardiac repair require functional vascularization and innervation for proper integration with the surrounding myocardium. The aim of this work was to study nerve sprouting and neovascularization in an acellular pericardial-derived scaffold used as a myocardial bioimplant. To this end, 17 swine were submitted to a myocardial infarction followed by implantation of a decellularized human pericardial-derived scaffold. After 30 days, animals were sacrificed and hearts were analyzed with hematoxylin/eosin and Masson's and Gallego's modified trichrome staining. Immunohistochemistry was carried out to detect nerve fibers within the cardiac bioimplant by using βIII tubulin and S100 labeling. Isolectin B4, smooth muscle actin, CD31, von Willebrand factor, cardiac troponin I, and elastin antibodies were used to study scaffold vascularization. Transmission electron microscopy was performed to confirm the presence of vascular and nervous ultrastructures. Left ventricular ejection fraction (LVEF), cardiac output (CO), stroke volume, end-diastolic volume, end-systolic volume, end-diastolic wall mass, and infarct size were assessed by using magnetic resonance imaging (MRI). Newly formed nerve fibers composed of several amyelinated axons as the afferent nerve endings of the heart were identified by immunohistochemistry. Additionally, neovessel formation occurred spontaneously as small and large isolectin B4-positive blood vessels within the scaffold. In summary, this study demonstrates for the first time the neoformation of vessels and nerves in cell-free cardiac scaffolds applied over infarcted tissue. Moreover, MRI analysis showed a significant improvement in LVEF (P = 0.03) and CO (P = 0.01) and a 43 % decrease in infarct size (P = 0.007).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Expression and Cellular Localization of 15-Hydroxy-Prostaglandin-Dehydrogenase in Abdominal Aortic Aneurysm

  • Solà-Villà, David
  • Dilmé, Jaume|||0000-0003-0127-0064
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Soto, Begoña|||0000-0002-5965-1292
  • Vila, Luis|||0000-0003-0150-6129
  • Escudero, José Román|||0000-0003-3929-6403
  • Martínez-González, José|||0000-0002-3894-7166
  • Camacho, Mercedes|||0000-0001-5970-3294
PGE has been implicated in abdominal aortic aneurysm (AAA) associated hypervascularization. PGE-metabolism involves 15-hydroxyprostaglandin-dehydrogenase (15-PGDH) the expression of which in AAA is unknown. The aim of this study was to examine the expression and cell distribution of 15-PGDH in AAA. Here, we show that 15-PGDH mRNA levels were significantly higher in aorta samples from patients undergoing AAA repair than in those from healthy multiorgan donors. Consequently, the ratio of metabolized PGE secreted by aortic samples was significantly higher in AAA. AAA production of total PGE and PGE metabolites correlated positively with PGI production, while the percentage of metabolized PGE correlated negatively with the total amount of PGE and with PGI. Transcript levels of 15-PGDH were statistically associated with leukocyte markers but did not correlate with microvascular endothelial cell markers. Immunohistochemistry revealed 15-PGDH in the areas of leukocyte infiltration in AAA samples, mainly associated with CD45-positive cells, but not in normal aorta samples. We provide new data concerning 15-PGDH expression in human AAA, showing that 15-PGDH is upregulated in AAA and mainly expressed in infiltrating leukocytes. Our data suggest that microvasculature was not involved in PGE catabolism, reinforcing the potential role of microvasculature derived PGE in AAA-associated hypervascularization.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Endothelial Progenitor Cells Predict Cardiovascular Events after Atherothrombotic Stroke and Acute Myocardial Infarction. A PROCELL Substudy

  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Regueiro, Ander|||0000-0001-5201-447X
  • Núñez, Julio|||0000-0003-1672-7119
  • Diaz-Ricart, Maribel|||0000-0003-1122-0052
  • Novella, Susana
  • Oliveras i Serrano, Anna|||0000-0002-5503-545X
  • Valverde, Miguel A.
  • Marrugat, Jaume|||0000-0003-3320-554X
  • Ois, Angel|||0000-0002-1375-5950
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Sanchís, Juan
  • Escolar, Ginès
  • Hermenegildo, Carlos
  • Heras, Magda
  • Roquer González, Jaume|||0000-0001-5992-2606
The aim of this study was to determine prognostic factors for the risk of new vascular events during the first 6 months after acute myocardial infarction (AMI) or atherothrombotic stroke (AS). We were interested in the prognostic role of endothelial progenitor cells (EPC) and circulating endothelial cells (CEC) Between February 2009 and July 2012, 100 AMI and 50 AS patients were consecutively studied in three Spanish centres. Patients with previously documented coronary artery disease or ischemic strokes were excluded. Samples were collected within 24h of onset of symptoms. EPC and CEC were studied using flow cytometry and categorized by quartiles. Patients were followed for up to 6 months. NVE was defined as new acute coronary syndrome, transient ischemic attack (TIA), stroke, or any hospitalization or death from cardiovascular causes. The variables included in the analysis included: vascular risk factors, carotid intima-media thickness (IMT), atherosclerotic burden and basal EPC and CEC count. Multivariate survival analysis was performed using Cox regression analysis. During follow-up, 19 patients (12.66%) had a new vascular event (5 strokes; 3 TIAs; 4 AMI; 6 hospitalizations; 1 death). Vascular events were associated with age (P = 0.039), carotid IMT≥0.9 (P = 0.044), and EPC count (P = 0.041) in the univariate analysis. Multivariate Cox regression analysis showed an independent association with EPC in the lowest quartile (HR: 10.33, 95%CI (1.22-87.34), P = 0.032] and IMT≥0.9 [HR: 4.12, 95%CI (1.21-13.95), P = 0.023]. Basal EPC and IMT≥0.9 can predict future vascular events in patients with AMI and AS, but CEC count does not affect cardiovascular risk.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

In vivo experience with natural scaffolds for myocardial infarction, the times they are a-changin'

  • Perea Gil, Isaac
  • Prat-Vidal, Cristina|||0000-0002-5621-1101
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
Treating a myocardial infarction (MI), the most frequent cause of death worldwide, remains one of the most exciting medical challenges in the 21st century. Cardiac tissue engineering, a novel emerging treatment, involves the use of therapeutic cells supported by a scaffold for regenerating the infarcted area. It is essential to select the appropriate scaffold material; the ideal one should provide a suitable cellular microenvironment, mimic the native myocardium, and allow mechanical and electrical coupling with host tissues. Among available scaffold materials, natural scaffolds are preferable for achieving these purposes because they possess myocardial extracellular matrix properties and structures. Here, we review several natural scaffolds for applications in MI management, with a focus on pre-clinical studies and clinical trials performed to date. We also evaluate scaffolds combined with different cell types and proteins for their ability to promote improved heart function, contractility and neovascularization, and attenuate adverse ventricular remodeling. Although further refinement is necessary in the coming years, promising results indicate that natural scaffolds may be a valuable translational therapeutic option with clinical impact in MI repair.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Single Amino Acid Deletion (ΔF1502) in the S6 Segment of Ca2.1 Domain III Associated with Congenital Ataxia Increases Channel Activity and Promotes Ca 2+ Influx

  • Bahamonde, María Isabel
  • Serra, Selma Angèlica
  • Drechsel, Oliver
  • Rahman, Rubayte
  • Marcé-Grau, Anna|||0000-0001-5762-4023
  • Prieto, Marta
  • Ossowski, Stephan|||0000-0002-7416-9568
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Fernández-Fernández, José Manuel|||0000-0003-2330-8449
Mutations in the CACNA1A gene, encoding the pore-forming Ca2.1 (P/Q-type) channel α subunit, result in heterogeneous human neurological disorders, including familial and sporadic hemiplegic migraine along with episodic and progressive forms of ataxia. Hemiplegic Migraine (HM) mutations induce gain-of-channel function, mainly by shifting channel activation to lower voltages, whereas ataxia mutations mostly produce loss-of-channel function. However, some HM-linked gain-of-function mutations are also associated to congenital ataxia and/or cerebellar atrophy, including the deletion of a highly conserved phenylalanine located at the S6 pore region of α domain III (ΔF1502). Functional studies of ΔF1502 Ca2.1 channels, expressed in Xenopus oocytes, using the non-physiological Ba 2+ as the charge carrier have only revealed discrete alterations in channel function of unclear pathophysiological relevance. Here, we report a second case of congenital ataxia linked to the ΔF1502 α mutation, detected by whole-exome sequencing, and analyze its functional consequences on Ca2.1 human channels heterologously expressed in mammalian tsA-201 HEK cells, using the physiological permeant ion Ca 2+. ΔF1502 strongly decreases the voltage threshold for channel activation (by ~ 21 mV), allowing significantly higher Ca 2+ current densities in a range of depolarized voltages with physiological relevance in neurons, even though maximal Ca 2+ current density through ΔF1502 Ca2.1 channels is 60% lower than through wild-type channels. ΔF1502 accelerates activation kinetics and slows deactivation kinetics of Ca2.1 within a wide range of voltage depolarization. ΔF1502 also slowed Ca2.1 inactivation kinetic and shifted the inactivation curve to hyperpolarized potentials (by ~ 28 mV). ΔF1502 effects on Ca2.1 activation and deactivation properties seem to be of high physiological relevance. Thus, ΔF1502 strongly promotes Ca 2+ influx in response to either single or trains of action potential-like waveforms of different durations. Our observations support a causative role of gain-of-function Ca2.1 mutations in congenital ataxia, a neurodevelopmental disorder at the severe-most end of CACNA1A -associated phenotypic spectrum
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Global DNA Methylation of Ischemic Stroke Subtypes

  • Soriano Tárraga, Carolina|||0000-0002-5635-273X
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Mola, Marina
  • Ois, Angel|||0000-0002-1375-5950
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Carrera, Caty|||0000-0002-0804-0969
  • Montaner, Joan|||0000-0003-4845-2279
  • Elosua, Roberto|||0000-0001-8235-0095
  • Roquer González, Jaume|||0000-0001-5992-2606
Ischemic stroke (IS), a heterogeneous multifactorial disorder, is among the leading causes of mortality and long-term disability in the western world. Epidemiological data provides evidence for a genetic component to the disease, but its epigenetic involvement is still largely unknown. Epigenetic mechanisms, such as DNA methylation, change over time and may be associated with aging processes and with modulation of the risk of various pathologies, such as cardiovascular disease and stroke. We analyzed 2 independent cohorts of IS patients. Global DNA methylation was measured by luminometric methylation assay (LUMA) of DNA blood samples. Univariate and multivariate regression analyses were used to assess the methylation differences between the 3 most common IS subtypes, large-artery atherosclerosis (LAA), small-artery disease (SAD), and cardio-aortic embolism (CE). A total of 485 IS patients from 2 independent hospital cohorts (n = 281 and n = 204) were included, distributed across 3 IS subtypes: LAA (78/281, 59/204), SAD (97/281, 53/204), and CE (106/281, 89/204). In univariate analyses, no statistical differences in LUMA levels were observed between the 3 etiologies in either cohort. Multivariate analysis, adjusted by age, sex, hyperlipidemia, and smoking habit, confirmed the lack of differences in methylation levels between the analyzed IS subtypes in both cohorts. Despite differences in pathogenesis, our results showed no global methylation differences between LAA, SAD, and CE subtypes of IS. Further work is required to establish whether the epigenetic mechanism of methylation might play a role in this complex disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Active Smoking Increases Microsomal PGE-Synthase-1/PGE-Receptor-4 Axis in Human Abdominal Aortic Aneurysms

  • Dilmé, Jaume|||0000-0003-0127-0064
  • Solà-Villà, David
  • Bellmunt Montoya, Sergi|||0000-0002-2851-720X
  • Romero, José María|||0000-0002-5969-5885
  • Escudero, José Román|||0000-0003-3929-6403
  • Camacho, Mercedes|||0000-0001-5970-3294
  • Vila, Luis|||0000-0003-0150-6129
Background. The cyclooxygenase- (COX-) 2/microsomal PGE-synthase- (mPGES-) 1/PGE-receptor- (EP-) 4 axis could play a key role in the physiopathology of abdominal aortic aneurysm (AAA) in humans. In this study, we investigated the influence of cardiovascular risk factors on the expression of the PGE pathway in human AAA. Methods. Aortic (n = 89) and plasma (n = 79) samples from patients who underwent AAA repair were collected. Patients were grouped according to risk factors. COX-isoenzymes, mPGES-1, EPs, α -actin, and CD45 and CD68 transcripts levels were quantified by QRT-PCR and plasma PGE metabolites by EIA. Results. Current smoking (CS) patients compared to no-CS had significantly higher local levels of mPGES-1 (P = 0.009), EP-4 (P = 0.007), and PGE metabolites plasma levels (P = 0.008). In the multiple linear regression analysis, these parameters remained significantly enhanced in CS after adding confounding factors. Results from association studies with cell type markers suggested that the increased mPGES-1/EP-4 levels were mainly associated with microvascular endothelial cells. Conclusions. This study shows that elements of the PGE pathway, which play an important role in AAA development, are increased in CS. These results provide insight into the relevance of tobacco smoking in AAA development and reinforce the potential of mPGES-1 and EP-4 as targets for therapy in AAA patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Role of HbA1c Determination in Detecting Unknown Glucose Disturbances in Ischemic Stroke

  • Roquer González, Jaume|||0000-0001-5992-2606
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Soriano, Carol
  • Ois, Angel|||0000-0002-1375-5950
To evaluate the usefulness of hemoglobin A1c (HbA1c) determinations during the acute ischemic stroke (IS) to identify undiagnosed glucose disturbances in a prospective series of patients with first-ever IS. Retrospective analysis of a prospective series of first-ever IS patients. Patients with previous diagnosis of diabetes mellitus (DM) were excluded from the study. Patients were classified as non-DM (HbA1c<5.7% and no previous evidence of 2 or more fasting blood glucose.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Circulating neprilysin hypothesis, A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?

  • Lupón, Josep|||0000-0002-5601-9611
  • Santiago Vacas, Evelyn|||0000-0001-7511-406X
  • Cediel, Germán|||0000-0001-9667-7507
  • Codina, Pau|||0000-0002-2469-5711
  • Domingo, Mar|||0000-0002-2935-1272
  • Revuelta-López, Elena|||0000-0001-8962-5936
  • Zamora, Elisabet|||0000-0001-5317-7481
  • Spitaleri, Giosafat|||0000-0002-0214-9082
  • Santesmases, Javier|||0000-0002-1226-1617
  • Núñez, Julio|||0000-0003-1672-7119
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
Circulating Neprilysin (sNEP) has emerged as a potential prognostic biomarker in heart failure (HF). In PARAGON-HF benefit of sacubitril/valsartan was only observed in patients with left ventricular ejection fraction (LVEF) ≤57%. We aimed to assess the prognostic value of sNEP in outpatients with HF and LVEF >57%, in comparison with patients with LVEF ≤57%. Consecutive HF outpatients were included from May-2006 to February-2016. The primary endpoint was the composite of all-cause death or HF hospitalization and the main secondary endpoint was the composite of cardiovascular death or HF hospitalization. For the later competing risk methods were used. sNEP was measured in 1428 patients (age 67.7±12.7, 70.3% men, LVEF 35.8% ±14), 144 of which had a LVEF >57%. sNEP levels did not significantly differ between LVEF groups (p = 0.31). During a mean follow-up of 6±3.9 years, the primary endpoint occurred in 979 patients and the secondary composite endpoint in 714 (in 111 and 84 of the 144 patients with LVEF >57%, respectively). sNEP was significantly associated with both composite endpoints. Age- and sex- adjusted Cox regression analyses showed higher hazard ratios for sNEP in patients with LVEF >57%, both for the primary (HR 1.37 [1.16-1.61] vs. 1.04 [0.97-1.11]) and the secondary (HR 1.38 [1.21-1.55] vs. 1.11 [1.04-1.18]) composite endpoints. sNEP prognostic value in patients with HF and LVEF >57% outperforms that observed in patients with lower LVEF. Precision medicine using sNEP may identify HF patients with preserved LVEF that may benefit from treatment with sacubitril/valsartan.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Adenosine a2a receptors are upregulated in peripheral blood mononuclear cells from atrial fibrillation patients

  • Godoy-Marín, Hector|||0000-0002-1534-6309
  • Duroux, Romain|||0000-0001-7099-1469
  • Jacobson, Kenneth A.|||0000-0001-8104-1493
  • Soler, Concepció|||0000-0001-6502-5012
  • Colino-Lage, Hildegard|||0000-0002-8290-6070
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Montiel, José|||0000-0002-3791-5218
  • Madsen, Leif Hove|||0000-0001-5493-3998
  • Ciruela, Francisco|||0000-0003-0832-3739
Atrial fibrillation (AF) is the most common form of cardiac arrhythmia seen in clinical practice. While some clinical parameters may predict the transition from paroxysmal to persistent AF, the molecular mechanisms behind the AF perpetuation are poorly understood. Thus, oxidative stress, calcium overload and inflammation, among others, are believed to be involved in AF-induced atrial remodelling. Interestingly, adenosine and its receptors have also been related to AF development and perpetuation. Here, we investigated the expression of adenosine A2A receptor (A2AR) both in right atrium biopsies and peripheral blood mononuclear cells (PBMCs) from non-dilated sinus rhythm (ndSR), dilated sinus rhythm (dSR) and AF patients. In addition, plasma adenosine content and adenosine deaminase (ADA) activity in these subjects were also determined. Our results revealed increased A2AR expression in the right atrium from AF patients, as previously described. Interestingly, increased levels of adenosine content and reduced ADA activity in plasma from AF patients were detected. An increase was observed when A2AR expression was assessed in PBMCs from AF subjects. Importantly, a positive correlation (P=0.001) between A2AR expression in the right atrium and PBMCs was observed. Overall, these results highlight the importance of the A2AR in AF and suggest that the evaluation of this receptor in PBMCs may be potentially be useful in monitoring disease severity and the efficacy of pharmacological treatments in AF patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients, A Report From the FANTASIIA Registry

  • Esteve-Pastor, María Asunción|||0000-0003-3104-3460
  • Ruiz-Ortiz, Martín|||0000-0002-1479-7044
  • Muñiz, Javier|||0000-0002-3087-2067
  • Roldán-Rabadán, Inmaculada|||0000-0003-1299-5298
  • Otero, Déborah
  • Cequier, Ángel|||0000-0002-3230-0011
  • Bertomeu-Martínez, Vicente|||0000-0002-3553-0963
  • Badimon, Lina|||0000-0002-9162-2459
  • Anguita-Sánchez, Manuel|||0000-0001-7875-7263
  • Lip, Gregory Y. H.|||0000-0002-7566-1626
  • Marín, Francisco|||0000-0001-7246-7708
Background: An integrated and holistic approach is increasingly advocated in patients with atrial fibrillation (AF), based on the "Atrial fibrillation Better Care (ABC) pathway: A, Avoid stroke with anticoagulation; B, better symptom management; C, cardiovascular and comorbidity risk management." The aim of this study was to examine the prevalence of adherence to each component of the ABC pathway and to analyze its impact on long-term prognosis in the "real-world" cohort of AF patients from the FANTASIIA registry. Methods: This prospective study included consecutive AF outpatients anticoagulated with direct oral anticoagulants (DOAC) or vitamin K antagonists (VKA) from June 2013 to October 2014. From the ABC pathway, adherence to the "A criterion" was defined by a time in the therapeutic range (TTR) ≥ 70% or correct dose with DOAC; "B criterion" adherence was defined by a European Heart Rhythm Association (EHRA) Symptom Scale I-II; and "C criterion" adherence was defined as optimized risk factors and comorbidity management. Baseline features and embolic events, severe bleeding, and all-cause and cardiovascular mortality rates up to 3 years of follow-up were analyzed, and a Cox multivariate analysis was performed to investigate the role of each component of the ABC pathway in predicting major events. Results: A total of 1,955 AF patients (age: 74.4 ± 9.4 years; 43.2% female patients) were included in this study: adherence to A criterion was observed in 920 (47.1%) patients; adherence to B criterion was observed in 1,791 (91.6%) patients; and adherence to C criterion was observed in 682 (34.8%) patients. Only 394 (20.2%) of the whole population had good control of AF according to the ABC pathway. After a median follow-up of 1,078 days (IQR: 766-1,113), adherence to A criterion was independently associated with reduced cardiovascular mortality [HR: 0.67, 95%CI (0.45-0.99); p = 0.048] compared with non-adherence. Adherence to the B criterion was independently associated with reduced stroke [HR: 0.28, 95%CI (0.14-0.59); p < 0.001], all-cause mortality [HR: 0.49, 95%CI (0.35-0.69); p < 0.001], cardiovascular mortality [HR: 0.39, 95%CI (0.25-0.62); p < 0.001], and major adverse cardiovascular events (MACE) [HR: 0.41, 95%CI (0.28-0.62); p < 0.001] compared with non-adherence. AF patients with C criterion adherence had a significantly lower risk of myocardial infarction [HR: 0.31, 95%CI (0.15-0.66); p < 0.001]. Fully adherent ABC patients had a significant reduction in MACE [HR: 0.64, 95%CI (0.42-0.99); p = 0.042]. Conclusion: In real-world anticoagulated AF patients from FANTASIIA registry, we observed a lack of adherence to integrated care management of AF following the ABC pathway. AF managed according to the ABC pathway was associated with a significant reduction in adverse outcomes during long follow-up, suggesting the benefit of a holistic and integrated approach to AF management.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation, A Report From the FANTASIIA Registry

  • Bertomeu-González, Vicente|||0000-0001-5309-0562
  • Moreno-Arribas, José|||0000-0002-4070-6476
  • Esteve-Pastor, María Asunción|||0000-0003-3104-3460
  • Roldán-Rabadán, Inmaculada|||0000-0003-1299-5298
  • Muñiz, Javier|||0000-0002-3087-2067
  • Raña-Míguez, Paula
  • Ruiz-Ortiz, Martín|||0000-0002-1479-7044
  • Cequier, Ángel|||0000-0002-3230-0011
  • Bertomeu-Martínez, Vicente|||0000-0002-3553-0963
  • Badimon, Lina|||0000-0002-9162-2459
  • Anguita-Sánchez, Manuel|||0000-0001-7875-7263
  • Lip, Gregory Y. H.|||0000-0002-7566-1626
  • Marín, Francisco|||0000-0001-7246-7708
Obesity and atrial fibrillation (AF) frequently coexist and independently increase mortality. We sought to assess the association between obesity and adverse events in patients receiving oral anticoagulants for AF. Consecutive AF outpatients receiving anticoagulant agents (both vitamin K antagonists and direct oral anticoagulants) were recruited into the FANTASIIA (Atrial fibrillation: influence of the level and type of anticoagulation on the incidence of ischemic and hemorrhagic stroke) registry. This observational, multicenter, and prospective registry of AF patients analyzes the quality of anticoagulation, incidence of events, and differences between oral anticoagulant therapies. We analyzed baseline patient characteristics according to body mass index, normal: <25 kg/m, overweight: 25-30 kg/m, and obese: ≥30 kg/m), assessing all-cause mortality, stroke, major bleeding and major adverse cardiovascular events (a composite of ischemic stroke, myocardial infarction, and total mortality) at 3 years' follow-up. In this secondary prespecified substudy, the association of weight on prognosis was evaluated. We recruited 1956 patients (56% men, mean age 73.8±9.4 years): 358 (18.3%) had normal body mass index, 871 (44.5%) were overweight, and 727 (37.2%) were obese. Obese patients were younger (P<0.01) and had more comorbidities. Mean time in the therapeutic range was similar across body mass index categories (P=0.42). After a median follow-up of 1070 days, 255 patients died (13%), 45 had a stroke (2.3%), 146 a major bleeding episode (7.5%) and 168 a major adverse cardiovascular event (8.6%). Event rates were similar between groups for total mortality (P=0.29), stroke (P=0.90), major bleeding (P=0.31), and major adverse cardiovascular events (P=0.24). On multivariate Cox analysis, body mass index was not independently associated with all-cause mortality, cardiovascular mortality, stroke, major bleeding, or major adverse cardiovascular events. In this prospective cohort of patients anticoagulated for AF, obesity was highly prevalent and was associated with more comorbidities, but not with poor prognosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The 4q25 variant rs13143308T links risk of atrial fibrillation to defective calcium homoeostasis

  • Herraiz-Martínez, Adela
  • Llach, Anna|||0000-0002-7486-1079
  • Tarifa, Carmen|||0000-0001-8954-6058
  • Gandía, Jorge
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Lozano-Velasco, Estefanía|||0000-0002-5615-2754
  • Serra, Selma A.|||0000-0002-2242-7713
  • Vallmitjana, Alexander
  • Vázquez Ruiz De Castroviejo, Eduardo
  • Benítez, Raúl|||0000-0002-8782-9406
  • Aránega, Amelia|||0000-0002-0046-9410
  • Muñoz-Guijosa, Christian|||0000-0002-0272-1704
  • Franco, Diego|||0000-0002-5669-7164
  • Cinca, Juan|||0000-0003-4819-4265
  • Madsen, Leif Hove|||0000-0001-5493-3998
Single nucleotide polymorphisms on chromosome 4q25 have been associated with risk of atrial fibrillation (AF) but the exiguous knowledge of the mechanistic links between these risk variants and underlying electrophysiological alterations hampers their clinical utility. Here, we tested the hypothesis that 4q25 risk variants cause alterations in the intracellular calcium homoeostasis that predispose to spontaneous electrical activity. Western blotting, confocal calcium imaging, and patch-clamp techniques were used to identify mechanisms linking the 4q25 risk variants rs2200733T and rs13143308T to defects in the calcium homoeostasis in human atrial myocytes. Our findings revealed that the rs13143308T variant was more frequent in patients with AF and that myocytes from carriers of this variant had a significantly higher density of calcium sparks (14.1 ± 4.5 vs. 3.1 ± 1.3 events/min, P = 0.02), frequency of transient inward currents (I TI) (1.33 ± 0.24 vs. 0.26 ± 0.09 events/min, P < 0.001) and incidence of spontaneous membrane depolarizations (1.22 ± 0.26 vs. 0.56 ± 0.17 events/min, P = 0.001) than myocytes from patients with the normal rs13143308G variant. These alterations were linked to higher sarcoplasmic reticulum calcium loading (10.2 ± 1.4 vs. 7.3 ± 0.5 amol/pF, P = 0.01), SERCA2 expression (1.37 ± 0.13 fold, P = 0.03), and RyR2 phosphorylation at ser2808 (0.67 ± 0.08 vs. 0.47 ± 0.03, P = 0.01) but not at ser2814 (0.28 ± 0.14 vs. 0.31 ± 0.14, P = 0.61) in patients carrying the rs13143308T risk variant. Furthermore, the presence of a risk variant or AF independently increased the I TI frequency and the increase in the I TI frequency observed in carriers of the risk variants was exacerbated in those with AF. By contrast, the presence of a risk variant did not affect the amplitude or properties of the L-type calcium current in patients with or without AF. Here, we identify the 4q25 variant rs13143308T as a genetic risk marker for AF, specifically associated with excessive calcium release and spontaneous electrical activity linked to increased SERCA2 expression and RyR2 phosphorylation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis

  • Clemente, Cristina
  • Rius i Gibert, Maria Cristina|||0000-0001-5189-6503
  • Alonso-Herranz, Laura
  • Martín-Alonso, Mara
  • Pollán, Ángela
  • Camafeita, Emilio|||0000-0002-4577-5331
  • Martínez, Fernando|||0000-0003-1904-5164
  • Mota, Rubén A.
  • Núñez, Vanessa
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Seiki, Motoharu
  • Martínez-González, José|||0000-0002-3894-7166
  • Andrés, Vicente|||0000-0002-0125-7209
  • Ricote, Mercedes
  • Arroyo, Alicia G.
Matrix metalloproteinases are involved in vascular remodeling. Little is known about their immune regulatory role in atherosclerosis. Here we show that mice deficient for MT4-MMP have increased adherence of macrophages to inflamed peritonea, and larger lipid deposits and macrophage burden in atherosclerotic plaques. We also demonstrate that MT4-MMP deficiency results in higher numbers of patrolling monocytes crawling and adhered to inflamed endothelia, and the accumulation of Mafb+ apoptosis inhibitor of macrophage (AIM)+ macrophages at incipient atherosclerotic lesions in mice. Functionally, MT4-MMP-null Mafb+AIM+ peritoneal macrophages express higher AIM and scavenger receptor CD36, are more resistant to apoptosis, and bind acLDL avidly, all of which contribute to atherosclerosis. CCR5 inhibition alleviates these effects by hindering the enhanced recruitment of MT4-MMP-null patrolling monocytes to early atherosclerotic lesions, thus blocking Mafb+AIM+ macrophage accumulation and atherosclerosis acceleration. Our results suggest that MT4-MMP targeting may constitute a novel strategy to boost patrolling monocyte activity in early inflammation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Macrophages of genetically characterized familial hypercholesterolaemia patients show up-regulation of LDL-receptor-related proteins

  • Escate, Rafael|||0000-0002-8448-7244
  • Padró, Teresa|||0000-0003-1921-954X
  • Borrell-Pages, Maria|||0000-0002-1759-9756
  • Suades, Rosa|||0000-0002-0193-3115
  • Aledo, Rosa
  • Mata, Pedro
  • Badimon, Lina|||0000-0002-9162-2459
Familial hypercholesterolaemia (FH) is a major risk for premature coronary heart disease due to severe long-life exposure to high LDL levels. Accumulation of LDL in the vascular wall triggers atherosclerosis with activation of the innate immunity system. Here, we have investigated (i) gene expression of LDLR and LRPs in peripheral blood cells (PBLs) and in differentiated macrophages of young FH-patients; and (ii) whether macrophage from FH patients have a differential response when exposed to high levels of atherogenic LDL. PBLs in young heterozygous genetically characterized FH patients have higher expression of LRP5 and LRP6 than age-matched healthy controls or patients with secondary hypercholesterolaemia. LRP1 levels were similar among groups. In monocyte-derived macrophages (MACs), LRP5 and LRP1 transcript levels did not differ between FHs and controls in resting conditions, but when exposed to agLDL, FH-MAC showed a highly significant up-regulation of LRP5, while LRP1 was unaffected. PBL and MAC cells from FH patients had significantly lower LDLR expression than control cells, independently of the lipid-lowering therapy. Furthermore, exposure of FH-MAC to agLDL resulted in a reduced expression of CD163, scavenger receptor with anti-inflammatory and atheroprotective properties. In summary, our results show for first time that LRPs, active lipid-internalizing receptors, are up-regulated in innate immunity cells of young FH patients that have functional LDLR mutations. Additionally, their reduced CD163 expression indicates less atheroprotection. Both mechanisms may play a synergic effect on the onset of premature atherosclerosis in FH patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia

  • Cubedo, Judit|||0000-0003-3291-9137
  • Padró, Teresa|||0000-0003-1921-954X
  • Alonso Karlezi, Rodrigo|||0000-0002-8119-1245
  • Mata, Pedro
  • Badimon, Lina|||0000-0002-9162-2459
HDL composition rather than HDL-cholesterol (HDL-C) levels seems to be a key determinant of HDL-induced atheroprotection. Heterozygous familial hypercholesterolemia (FH) patients, with lifelong exposure to high LDL levels, show a high prevalence of premature coronary artery disease. We hypothesized that HDL of FH patients might have a modified protein composition and investigated the proteomic signature of HDL obtained from FH patients and their unaffected relatives. HDLs were characterized by 2D electrophoresis/MS in 10 families from the SAFEHEART cohort (3 individuals/family: 2 with genetic FH diagnosis and 1 non-FH relative) clinically characterized and treated as per guidelines. FH patients had lower apoA-I levels and a differential HDL distribution profile of apoL1 and apoA-IV. ELISA validation revealed decreased apoL1 serum levels in FH patients. ApoL1 levels were able to predict presentation of an ischemic cardiac event, and apoL1/HDL-C ratio was associated with the survival rate after the event. FH patients who died because of a fatal cardiac event had lower apoL1 and LCAT content in HDL3 an average of 3.5 years before the event than those who survived. Changes in HDL protein composition could affect patients prognosis. The proteomic profile of apoL1 is modified in HDLs of high cardiovascular risk patients, and apoL1 plasma levels are significantly lower in serum and in HDL3 of patients that will suffer an adverse cardiac event within 3 years. Cubedo, J., T. Padr, R. Alonso, P. Mata, and L. Badimon. ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MiR-17 and -20a target the neuron-derived orphan receptor-1 (NOR-1) in vascular endothelial cells

  • Sambri, Irene|||0000-0003-3500-6958
  • Crespo García, Javier|||0000-0001-8248-0172
  • Aguiló, Silvia|||0000-0003-0672-8388
  • Ingrosso, Diego
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Martínez-González, José|||0000-0002-3894-7166
Neuron-derived orphan receptor-1 (NOR-1) plays a major role in vascular biology by controlling fibroproliferative and inflammatory responses. Because microRNAs (miRNAs) have recently emerged as key players in the regulation of gene expression in the vasculature, here we have investigated the regulation of NOR-1 by miRNAs in endothelial cells. Computational algorithms suggest that NOR-1 could be targeted by members of the miR-17 family. Accordingly, ectopic over-expression of miR-17 or miR-20a in endothelial cells using synthetic premiRNAs attenuated the up-regulation of NOR-1 expression induced by VEGF (as evidenced by real time PCR, Western blot and immunocitochemistry). Conversely, the antagonism of these miRNAs by specific antagomirs prevented the down-regulation of NOR-1 promoted by miR-17 or miR-20a in VEGF-stimulated cells. Disruption of the miRNANOR- 1 mRNA interaction using a custom designed target protector evidenced the selectivity of these responses. Further, luciferase reporter assays and seed-sequence mutagenesis confirmed that miR-17 and -20a bind to NOR-1 3'-UTR. Finally, miR-17 and -20a ameliorated the up-regulation of VCAM-1 mediated by NOR-1 in VEGF-stimulated cells. Therefore, miR-17 and -20a target NOR-1 thereby regulating NOR-1-dependent gene expression.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A novel truncated form of apolipoprotein A-I transported by dense LDL is increased in diabetic patients

  • Cubedo, Judit|||0000-0003-3291-9137
  • Padró, Teresa|||0000-0003-1921-954X
  • García-Arguinzonis, Maisa|||0000-0001-6749-5026
  • Vilahur, Gemma|||0000-0002-2828-8873
  • Miñambres, Inka|||0000-0002-0899-3938
  • Pou, Josep Maria
  • Ybarra, Juan
  • Badimon, Lina|||0000-0002-9162-2459
Diabetic (DM) patients have exacerbated atherosclerosis and high CVD burden. Changes in lipid metabolism, lipoprotein structure, and dysfunctional HDL are characteristics of diabetes. Our aim was to investigate whether serum ApoA-I, the main protein in HDL, was biochemically modified in DM patients. By using proteomic technologies, we have identified a 26 kDa ApoA-I form in serum. MS analysis revealed this 26 kDa form as a novel truncated variant lacking amino acids 1-38, ApoA-IΔ(1-38). DM patients show a 2-fold increase in ApoA-IΔ(1-38) over nondiabetic individuals. ApoA-IΔ(1-38) is found in LDL, but not in VLDL or HDL, with an increase in LDL3 and LDL4 subfractions. To identify candidate mechanisms of ApoA-I truncation, we investigated potentially involved enzymes by in silico data mining, and tested the most probable molecule in an established animal model of diabetes. We have found increased hepatic cathepsin D activity as one of the potential proteases involved in ApoA-I truncation. Cathepsin D-cleaved ApoA-I exhibited increased LDL binding affinity and decreased antioxidant activity against LDL oxidation. In conclusion, we show for the first time: a) presence of a novel truncated ApoA-I form, ApoA-IΔ(1-38), in human serum; b) ApoA-IΔ(1-38) is transported by LDL; c) ApoA-IΔ(1-38) is increased in dense LDL fractions of DM patients; and d) cathepsin D-ApoA-I truncation may lead to ApoA-IΔ(1-38) binding to LDLs, increasing their susceptibility to oxidation and contributing to the high cardiovascular risk of DM patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats

  • Miana, María
  • Galán, María|||0000-0002-4758-8388
  • Martínez-Martínez, Ernesto
  • Varona, Saray|||0000-0002-7375-313X
  • Jurado-López, Raquel|||0000-0002-9149-1073
  • Bausa-Miranda, Belén
  • Antequera, Alfonso
  • Luaces, María
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Cachofeiro, Victoria
Extracellular matrix (ECM) remodelling of the adipose tissue plays a pivotal role in the pathophysiology of obesity. The lysyl oxidase (LOX) family of amine oxidases, including LOX and LOX-like (LOXL) isoenzymes, controls ECM maturation, and upregulation of LOX activity is essential in fibrosis; however, its involvement in adipose tissue dysfunction in obesity is unclear. In this study, we observed that LOX is the main isoenzyme expressed in human adipose tissue and that its expression is strongly upregulated in samples from obese individuals that had been referred to bariatric surgery. LOX expression was also induced in the adipose tissue from male Wistar rats fed a high-fat diet (HFD). Interestingly, treatment with β-aminopropionitrile (BAPN), a specific and irreversible inhibitor of LOX activity, attenuated the increase in body weight and fat mass that was observed in obese animals and shifted adipocyte size toward smaller adipocytes. BAPN also ameliorated the increase in collagen content that was observed in adipose tissue from obese animals and improved several metabolic parameters - it ameliorated glucose and insulin levels, decreased homeostasis model assessment (HOMA) index and reduced plasma triglyceride levels. Furthermore, in white adipose tissue from obese animals, BAPN prevented the downregulation of adiponectin and glucose transporter 4 (GLUT4), as well as the increase in suppressor of cytokine signaling 3 (SOCS3) and dipeptidyl peptidase 4 (DPP4) levels, triggered by the HFD. Likewise, in the TNFα-induced insulin-resistant 3T3-L1 adipocyte model, BAPN prevented the downregulation of adiponectin and GLUT4 and the increase in SOCS3 levels, and consequently normalised insulin-stimulated glucose uptake. Therefore, our data provide evidence that LOX plays a pathologically relevant role in the metabolic dysfunction induced by obesity and emphasise the interest of novel pharmacological interventions that target adipose tissue fibrosis and LOX activity for the clinical management of this disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

K domain CR9 of low density lipoprotein (LDL) receptor-related protein 1 (LRP1) is critical for aggregated LDL-induced foam cell formation from human vascular smooth muscle cells

  • Costales, Paula
  • Fuentes-Prior, Pablo|||0000-0002-6618-3204
  • Castellano, José
  • Revuelta-López, Elena|||0000-0001-8962-5936
  • Corral-Rodríguez, Maria Ángeles|||0000-0002-7875-1694
  • Nasarre, Laura
  • Badimon, Lina|||0000-0002-9162-2459
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
Low density lipoprotein receptor-related protein (LRP1) mediates the internalization of aggregated LDL (AgLDL), which in turn increases the expression of LRP1 in human vascular smooth muscle cells (hVSMCs). This positive feedback mechanism is thus highly efficient to promote the formation of hVSMC foam cells, a crucial vascular component determining the susceptibility of atherosclerotic plaque to rupture. Here we have determined the LRP1 domains involved in AgLDL recognition with the aim of specifically blocking AgLDL internalization in hVSMCs. The capacity of fluorescently labeled AgLDL to bind to functional LRP1 clusters was tested in a receptor-ligand fluorometric assay made by immobilizing soluble LRP1 "minireceptors"(sLRP1-II, sLRP1-III, and sLRP1-IV) recombinantly expressed in CHO cells. This assay showed that AgLDL binds to cluster II. We predicted three well exposed and potentially immunogenic peptides in the CR7-CR9 domains of this cluster (termed P1 (Cys-Glu), P2 (Asp-Cys), and P3 (Gly-Cys)). AgLDL, but not native LDL, bound specifically and tightly to P3-coated wells. Rabbit polyclonal antibodies raised against P3 prevented AgLDL uptake by hVSMCs and were almost twice as effective as anti-P1 and anti-P2 Abs in reducing intracellular cholesteryl ester accumulation. Moreover, anti-P3 Abs efficiently prevented AgLDL-induced LRP1 up-regulation and counteracted the down-regulatory effect of AgLDL on hVSMC migration. In conclusion, domain CR9 appears to be critical for LRP1-mediated AgLDL binding and internalization in hVSMCs. Our results open new avenues for an innovative anti-VSMC foam cell-based strategy for the treatment of vascular lipid deposition in atherosclerosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

LRP5 deficiency down-regulates Wnt signalling and promotes aortic lipid infiltration in hypercholesterolaemic mice

  • Borrell-Pages, Maria|||0000-0002-1759-9756
  • Romero, July Carolina
  • Badimon, Lina|||0000-0002-9162-2459
Low-density lipoprotein receptor-related protein 5 (LRP5) is a member of the LDLR family that orchestrates cholesterol homoeostasis. The role of LRP5 and the canonical Wnt pathway in the vascular wall of dyslipidaemic animals remains unknown. In this study, we analysed the role of LRP5 and the Wnt signalling pathway in mice fed a hypercholesterolaemic diet (HC) to trigger dyslipidaemia. We show that Lrp5 mice had larger aortic lipid infiltrations than wild-type mice, indicating a protective role for LRP5 in the vascular wall. Three members of the LDLR family, Lrp1, Vldlr and Lrp6, showed up-regulated gene expression levels in aortas of Lrp5 mice fed a hypercholesterolaemic diet. HC feeding in Lrp5 mice induced higher macrophage infiltration in the aortas and accumulation of inflammatory cytokines in blood. Wnt/β-CATENIN signalling proteins were down-regulated in HC Lrp5 mice indicating that LRP5 regulates the activation of Wnt signalling in the vascular wall. In conclusion, our findings show that LRP5 and the canonical Wnt pathway down-regulation regulate the dyslipidaemic profile by promoting lipid and macrophage retention in the vessel wall and increasing leucocyte-driven systemic inflammation.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Reduced high-density lipoprotein cholesterol: a valuable, independent prognostic marker in peripheral arterial disease

  • Martínez Aguilar, Esther
  • Orbe, Josune
  • Fernández-Montero, Alejandro
  • Fernández Alonso, Sebastián
  • Rodríguez, José Antonio
  • Fernández Alonso, Leopoldo
  • Páramo, José A.
  • Roncal Mancho, Carmen
Objective The prognosis of patients with peripheral arterial disease (PAD) is characterized by an exceptionally high risk for myocardial infarction, ischemic stroke, and death; however, studies in search of new prognostic biomarkers in PAD are scarce. Even though low levels of high-density lipoprotein cholesterol (HDL-C) have been associated with higher risk of cardiovascular (CV) complications and death in different atherosclerotic diseases, recent epidemiologic studies have challenged its prognostic utility. The aim of this study was to test the predictive value of HDL-C as a risk factor for ischemic events or death in symptomatic PAD patients. Methods Clinical and demographic parameters of 254 symptomatic PAD patients were recorded. Amputation, ischemic coronary disease, cerebrovascular disease, and all-cause mortality were recorded during a mean follow-up of 2.7 years. Results Multivariate analyses showed that disease severity (critical limb ischemia) was significantly reduced in patients with normal HDL-C levels compared with the group with low HDL-C levels (multivariate analysis odds ratio, 0.09; 95% confidence interval [CI], 0.03-0.24). A decreased risk for mortality (hazard ratio, 0.46; 95% CI, 0.21-0.99) and major adverse CV events (hazard ratio, 0.38; 95% CI, 0.16-0.86) was also found in patients with normal vs reduced levels of HDL-C in both Cox proportional hazards models and Kaplan-Meier estimates, after adjustment for confounding factors. Conclusions Reduced HDL-C levels were significantly associated with higher risk for development of CV complications as well as with mortality in PAD patients. These findings highlight the usefulness of this simple test for early identification of PAD patients at high risk for development of major CV events., This work was supported by the Foundation for Applied Medical Research, University of Navarra (Pamplona, Spain); European Fund for Economic and Regional Development (FEDER) funds (FIS PI14/01152); and the Ministry of Economy and Competitiveness, Institute of Health Carlos III (RIC [RD12/ 0042/0009] and CIBER-CV [CB16/11/00371]).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease

  • Martínez Aguilar, Esther
  • Gómez-Rodríguez, Violeta
  • Orbe, Josune
  • Rodríguez, José Antonio
  • Fernández Alonso, Leopoldo
  • Roncal Mancho, Carmen
  • Páramo, José A.
Objective Peripheral arterial disease (PAD) is associated with poor prognosis in terms of cardiovascular (CV) morbidity and mortality. Matrix metalloproteinases (MMPs) contribute to vascular remodeling by degrading extracellular matrix components and play a role in atherosclerosis as demonstrated for MMP-10 (stromelysin-2). This study analyzed MMP-10 levels in PAD patients according to disease severity and CV risk factors and evaluated the prognostic value of MMP-10 for CV events and mortality in lower limb arterial disease after a follow-up period of 2 years. Methods MMP-10 was measured by enzyme-linked immunosorbent assay in 187 PAD patients and 200 sex-matched controls. Results PAD patients presented with increased levels of MMP-10 (702 ± 326 pg/mL control vs 946 ± 473 pg/mL PAD; P <.001) and decreased levels of tissue inhibitor of matrix metalloproteinase 1 (312 ± 117 ng/mL control vs 235 ± 110 ng/mL PAD; P <.001) compared with controls. Among PAD patients, those with critical limb ischemia (n = 88) showed higher levels of MMP-10 (1086 ± 478 pg/mL vs 822 ± 436 pg/mL; P <.001) compared with those with intermittent claudication (n = 99), whereas the MMP-10/tissue inhibitor of matrix metalloproteinase 1 ratio remained similar. The univariate analysis showed an association between MMP-10, age (P =.015), hypertension (P =.021), and ankle-brachial index (P =.006) in PAD patients that remained significantly associated with PAD severity after adjustment for other CV risk factors. Patients with the highest MMP-10 tertile had an increased incidence of all-cause mortality and CV mortality (P <.03). Conclusions Our results suggest that MMP-10 is associated with severity and poor outcome in PAD., This work was supported by the "UTE project CIMA" (University of Navarra) and Red de Investigación Cardiovascular RIC ( D12/0042/0009 ). V.G.R. was supported by a fellowship from the Foundation for Applied Medical Research (FIMA). C.R. was supported by the Spanish Ministry of Science and Innovation (MICINN-PTQ-09-02-01941).